<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
<journal-id journal-id-type="pmc">ploscomp</journal-id><journal-title-group>
<journal-title>PLoS Computational Biology</journal-title></journal-title-group>
<issn pub-type="ppub">1553-734X</issn>
<issn pub-type="epub">1553-7358</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PCOMPBIOL-D-13-02199</article-id>
<article-id pub-id-type="doi">10.1371/journal.pcbi.1003899</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Biotechnology</subject><subj-group><subject>Bioengineering</subject><subj-group><subject>Synthetic bioengineering</subject><subj-group><subject>Macromolecular engineering</subject><subj-group><subject>Protein engineering</subject><subj-group><subject>Directed evolution</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Computational biology</subject><subj-group><subject>Population modeling</subject><subj-group><subject>Infectious disease modeling</subject></subj-group></subj-group></subj-group><subj-group><subject>Plant science</subject><subj-group><subject>Plant pathology</subject><subj-group><subject>Infectious disease epidemiology</subject></subj-group></subj-group></subj-group><subj-group><subject>Evolutionary biology</subject><subj-group><subject>Evolutionary processes</subject><subj-group><subject>Evolutionary adaptation</subject></subj-group></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Immunology</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Major histocompatibility complex</subject></subj-group></subj-group><subj-group><subject>Immune response</subject></subj-group></subj-group><subj-group><subject>Theoretical biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Epidemiology</subject></subj-group><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>AIDS</subject></subj-group></subj-group><subj-group><subject>Sexually transmitted diseases</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Immuno-epidemiological Modeling of HIV-1 Predicts High Heritability of the Set-Point Virus Load, while Selection for CTL Escape Dominates Virulence Evolution</article-title>
<alt-title alt-title-type="running-head">Set-Point Evolution and CTL Escape of HIV-1</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>van Dorp</surname><given-names>Christiaan H.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>van Boven</surname><given-names>Michiel</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>de Boer</surname><given-names>Rob J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Theoretical Biology and Bioinformatics, Universiteit Utrecht, Utrecht, The Netherlands</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>National Institute for Public Health and the Environment, Bilthoven, The Netherlands</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Regoes</surname><given-names>Roland R.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>ETH Zurich, Switzerland</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">C.H.vanDorp@uu.nl</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: CHvD MvB RJdB. Performed the experiments: CHvD. Analyzed the data: CHvD MvB RJdB. Wrote the paper: CHvD MvB RJdB.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>12</month><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>18</day><month>12</month><year>2014</year></pub-date>
<volume>10</volume>
<issue>12</issue>
<elocation-id>e1003899</elocation-id>
<history>
<date date-type="received"><day>16</day><month>12</month><year>2013</year></date>
<date date-type="accepted"><day>7</day><month>9</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>van Dorp et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>It has been suggested that HIV-1 has evolved its set-point virus load to be optimized for transmission. Previous epidemiological models and studies into the heritability of set-point virus load confirm that this mode of adaptation within the human population is feasible. However, during the many cycles of replication between infection of a host and transmission to the next host, HIV-1 is under selection for escape from immune responses, and not transmission. Here we investigate with computational and mathematical models how these two levels of selection, within-host and between-host, are intertwined. We find that when the rate of immune escape is comparable to what has been observed in patients, immune selection within hosts is dominant over selection for transmission. Surprisingly, we do find high values for set-point virus load heritability, and argue that high heritability estimates can be caused by the ‘footprints’ left by differing hosts' immune systems on the virus.</p>
</abstract>
<abstract abstract-type="summary"><title>Author Summary</title>
<p>HIV-1 is a relatively young virus, being introduced in the human population somewhere between 1884 and 1924. Yet, previous studies suggest that the virus has already evolved to be efficiently transmitted among humans. Efficient transmission occurs when the set-point virus load, the semi-stable number of virus particles in the blood during the asymptomatic phase, is intermediate (approximately <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e001" xlink:type="simple"/></inline-formula> particles/ml). At this virus load level, individuals remain asymptomatic for a long period (7.0 years on average), and still remain sufficiently infectious. In this study, we model the combined immunological and epidemiological dynamics of HIV-1 to explore whether population-level adaptation is feasible. We show that strong selective forces within the host are expected to dominate the much weaker population-level selection, unless the within-host dynamics of immune escape becomes exceedingly slow. Surprisingly, our analyses yield high levels of set-point virus load heritability, as observed in human populations. In the model, heritability of set-point virus load partially results from an immunological ‘footprint’ of the host-virus interaction in transmitting hosts, affecting the receiving hosts' virus load.</p>
</abstract>
<funding-group><funding-statement>This research was funded by NWO (<ext-link ext-link-type="uri" xlink:href="http://www.nwo.nl" xlink:type="simple">www.nwo.nl</ext-link>). Grant number: 645.000.002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="17"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Human immunodeficiency virus type 1 (HIV-1) evolves under two levels of selection. On the one hand, there is within-host selection for immune escape. On the other hand, selection on the population-level acts on infectiousness and virulence. In this paper, we explore how these two levels of selection are intertwined, keeping in mind the massive heterogeneity of the hosts with respect to their cellular immune responses.</p>
<p>A HIV-1 infection can be separated into three phases: the acute phase, the asymptomatic phase and the symptomatic (or AIDS) phase. During the acute phase, the virus establishes high virus loads (the number of HIV-1 RNA copies per ml blood plasma) <xref ref-type="bibr" rid="pcbi.1003899-Little1">[1]</xref>, until the CD4<sup>+</sup> target cells are depleted <xref ref-type="bibr" rid="pcbi.1003899-Phillips1">[2]</xref>, and adaptive immune responses start limiting viral reproduction. The virus load then drops to a semi-stable level called the set-point. This marks the beginning of the asymptomatic or chronic phase, during which the partially restored CD4<sup>+</sup> T-cell count gradually drops, and at some point patients develop AIDS.</p>
<p>The set-point virus load (spVL) differs markedly between individuals. In untreated patients, spVL ranges from 10<sup>2</sup> to 10<sup>6</sup> copies/ml. The origin of this variation is an extensively researched topic, and explanations include host and viral factors. For instance, host factors incorporate the association between the set-point and the Human Leukocyte Antigen (HLA) haplotype, which is important for cellular immunity <xref ref-type="bibr" rid="pcbi.1003899-Fellay1">[3]</xref>–<xref ref-type="bibr" rid="pcbi.1003899-TheInternationalHIVControllers1">[6]</xref>. The observation that the spVL is to some extent heritable <xref ref-type="bibr" rid="pcbi.1003899-Hollingsworth1">[7]</xref>–<xref ref-type="bibr" rid="pcbi.1003899-Tang1">[14]</xref>, suggests that viral genetic factors sway the set-point too. The exact extent of this heritability is unknown, as estimates range from 6% to 59%.</p>
<p>spVL is related to infectiousness and virulence. Patients with a higher spVL tend to be more infectious <xref ref-type="bibr" rid="pcbi.1003899-Wawer1">[15]</xref>, but also develop AIDS more rapidly <xref ref-type="bibr" rid="pcbi.1003899-Mellors1">[16]</xref>, resulting in a trade-off between infectiousness and the length of the asymptomatic phase. This life history trade-off was identified by Fraser et al. <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>, and opens the door for HIV-1 adaptation with respect to transmission by means of spVL evolution. Certain spVLs (around <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e002" xlink:type="simple"/></inline-formula> copies/ml) allow a HIV-1 strain to cause more secondary infections than strains with lower or higher set-points. A strain that establishes on average this optimal set-point should therefore become more abundant in the population. The striking observation is that, although large variation in set-points exists, most HIV-1 infected patients show a set-point close to the transmission-optimal value <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>. Moreover, mathematical models show that this adaptation can take place within realistic time scales <xref ref-type="bibr" rid="pcbi.1003899-Shirreff1">[18]</xref>, given the heritability estimates of spVL <xref ref-type="bibr" rid="pcbi.1003899-Hollingsworth1">[7]</xref>, and HIV-1's likely dates of origin <xref ref-type="bibr" rid="pcbi.1003899-Worobey1">[19]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Sharp1">[20]</xref>.</p>
<p>In such mathematical models, HIV-1's population-level fitness (measured in terms of the basic reproduction number <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e003" xlink:type="simple"/></inline-formula>) is only constrained by the life history trade-off, and environment- and mutation-induced spVL-variation. It is therefore quite intuitive that in such a model evolution leads to intermediate levels of spVL <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Shirreff1">[18]</xref>. The inclusion of directed within-host evolution in such models introduces an extra constraint on the population-level fitness; one which dominates the evolutionary outcome, unless within-host selection is exceedingly weak. For a homogeneous host population, this has been shown recently by Lythgoe et al. <xref ref-type="bibr" rid="pcbi.1003899-Lythgoe1">[21]</xref>, and they suggest that within-host evolution of traits affecting virus load must be slow. Below we argue that ‘short-sightedness’ [<italic>sensu</italic> 21, 22], i.e., the life history trade-off has no apparent effect on the evolutionary outcome, can easily be understood when the host population is homogeneous. However, in a much more realistic situation where HIV-1 needs to escape from immune responses that vary markedly between individuals, the same intuition for the effect of directed within-host evolution can no longer be applied, and needs to be revised.</p>
<p>In this study, we explicitly incorporate such immune selection and massive host-heterogeneity with respect to immune responses in a nested epidemiological model. We investigate whether spVL evolution of HIV-1 is influenced by the virus' life history trade-off. Our model predicts that within-host immune selection has a major influence on population-wide spVL evolution. Thus, both Lythgoe's and our model predict short-sighted spVL evolution. However, we do not agree that within-host evolution must therefore be slow. Throughout the paper, we use the term ‘between-host adaptation’ for evolutionary dynamics where HIV-1's life history trade-off notably affects the evolution of spVL. The term ‘within-host selection’ refers to selection for immune escape and reversion of deleterious mutations.</p>
<p>At the same time, we use our model to investigate spVL heritability. We argue that high heritability can be a result of HIV-1 rapidly escaping immune responses, and the between-individual variation of these responses. We emphasize that spVL heritability caused by such a mechanism does not provide support for between-host adaptation.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>An immuno-epidemiological model</title>
<p>Our approach combines a caricature model for immune escape with a susceptible-infectious (SI) model for HIV-1 transmission. Both the within-host and the between-host simulations are discrete-event and individual based. The technical details are given in Methods. Here we give an intuitive exposition.</p>
<p>Cytotoxic T-Lymphocyte (CTL) responses are arguably important for controlling HIV-1 virus load <xref ref-type="bibr" rid="pcbi.1003899-Schmitz1">[23]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Regoes1">[24]</xref>. Human cells notify the cellular immune system about their proteome by presenting peptides on HLA molecules. On infected cells, a subset of these peptides originate from viral proteins. If a CTL clone detects such a foreign peptide, it can kill the infected cell, and the peptide (in its proper HLA context) is called an epitope. Not all peptides can be presented by the HLA molecules of a host, and HIV-1 can escape from CTL recognition by mutating amino acids in its peptides to prevent presentation by the host's HLA molecules <xref ref-type="bibr" rid="pcbi.1003899-Liu1">[25]</xref>–<xref ref-type="bibr" rid="pcbi.1003899-Henn1">[27]</xref>.</p>
<p>Due to HLA-polymorphism, the particular subset of all peptides that can be presented by a host's HLA molecules (the binding repertoire) differs strongly between individuals <xref ref-type="bibr" rid="pcbi.1003899-Goulder1">[28]</xref>. In our model we incorporate this by assuming that a wild-type virus has <italic>n</italic> peptides that can be presented in the population. A particular host can present a subset of size <italic>k</italic> of these <italic>n</italic> peptides. During infection, we assume that mutations in the <italic>n</italic> potentially recognized peptides occur according to a Markov process. Some of these mutations will result in CTL escape (escape mutations). In this case, the mutant takes over the viral population in that host. Naturally, if two hosts have have a common peptide in their binding repertoires, the mutated peptide is a CTL escape for both hosts.</p>
<p>In line with evidence, we assume that escape mutations in HIV-1 come with a fitness cost <xref ref-type="bibr" rid="pcbi.1003899-Goepfert1">[29]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Prince1">[30]</xref>. The total fitness effect of an escape mutation, resulting from immune escape and its fitness cost, must be positive before the escape mutant can replace the dominant HIV-1 strain in the host. In order to model this, we use the virus load in the asymptomatic phase as a measure for within-host fitness. An immune response causes a reduction <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e004" xlink:type="simple"/></inline-formula> in the log<sub>10</sub> virus load, and a fitness cost of any mutation reduces the log<sub>10</sub> virus load by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e005" xlink:type="simple"/></inline-formula>. The total fitness effect of an escape mutation is then a <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e006" xlink:type="simple"/></inline-formula> increase in the log<sub>10</sub> virus load. In the simulations, we choose <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e007" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e008" xlink:type="simple"/></inline-formula> so that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e009" xlink:type="simple"/></inline-formula> lies within estimated ranges <xref ref-type="bibr" rid="pcbi.1003899-Kadolsky1">[31]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Kiepiela1">[32]</xref>. Qualitatively, our results do not depend on these particular choices for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e010" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e011" xlink:type="simple"/></inline-formula>, as long as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e012" xlink:type="simple"/></inline-formula> (results not shown).</p>
<p>Certain hosts have an efficient immune response to HIV-1. This can partially be explained by HLA-type. For instance, HLA-B*57, B*27, B*58 and B*18 are associated with a low spVL. HIV-1 is able to escape immune responses in hosts with these HLA-types, but the associated fitness costs tend to cripple the virus <xref ref-type="bibr" rid="pcbi.1003899-Liu1">[25]</xref>. When such a crippled virus is transmitted to the next host, lacking the protective HLA-type, the virus load in this secondary host can remain low for a long time <xref ref-type="bibr" rid="pcbi.1003899-Goepfert1">[29]</xref>. After a while, the crippled virus reverts the deleterious mutations, since the immune pressure causing these crippling mutations is not present in the secondary host <xref ref-type="bibr" rid="pcbi.1003899-Leslie2">[33]</xref>. We propose that this effect is not only restricted to known protective HLA-types, but holds more generally [e.g., see 34]. We model this similar to immune escape. As a result of immune escape in previous hosts, a viral strain may carry a number of deleterious mutations. These mutations can revert to the wild-type, again according to a Markov process.</p>
<p>In summary, our model for the log<sub>10</sub> virus load <italic>V</italic> is [cf. 35]<disp-formula id="pcbi.1003899.e013"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e013" xlink:type="simple"/></disp-formula>where <italic>V</italic><sub>max</sub> is the log<sub>10</sub> virus load of a HIV-1 strain without deleterious mutations in the absence of CTL-responses (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e014" xlink:type="simple"/></inline-formula>), e.g., the high virus load observed in a CD8<sup>+</sup> T cell depleted individual <xref ref-type="bibr" rid="pcbi.1003899-Schmitz1">[23]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Jin1">[36]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Gaufin1">[37]</xref>. The integer <italic>e</italic> represents the number of escape mutations in a host (and hence, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e015" xlink:type="simple"/></inline-formula> equals the number of immune responses), and <italic>f</italic> denotes the number of deleterious mutations. In other words, <italic>f</italic> equals the number of mutated peptides outside the current host's binding repertoire.</p>
<p>We assume that escapes and reversions appear at a rate proportional to the number of immune responses and deleterious mutations, respectively. Hence <disp-formula id="pcbi.1003899.e016"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e016" xlink:type="simple"/></disp-formula>where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e017" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e018" xlink:type="simple"/></inline-formula> are the ‘per-peptide’ rate of escape and reversion, respectively. We will refer to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e019" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e020" xlink:type="simple"/></inline-formula> as ‘mutation rates’. Keep in mind, however, that our model of escape and reversion is quite phenomenological. The rates <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e021" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e022" xlink:type="simple"/></inline-formula> are a combination of many factors, such as the error rate during reverse transcriptase and the fixation rate. Moreover, the rates <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e023" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e024" xlink:type="simple"/></inline-formula> should in reality depend on the virus load. We simplify this dependence by assuming that the rates differ only between disease phases. In the acute and AIDS phase the per-peptide rates are high and in the asymptomatic phase, these rates are lower. Instead of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e025" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e026" xlink:type="simple"/></inline-formula>, we therefore take distinct parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e027" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e028" xlink:type="simple"/></inline-formula> for the per-peptide mutation rate in the acute (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e029" xlink:type="simple"/></inline-formula>), asymptomatic (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e030" xlink:type="simple"/></inline-formula>) and AIDS (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e031" xlink:type="simple"/></inline-formula>) phase. We choose <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e032" xlink:type="simple"/></inline-formula> with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e033" xlink:type="simple"/></inline-formula>, meaning that reversion is slower than escape (see <xref ref-type="table" rid="pcbi-1003899-t001">Table 1</xref> for the exact parameterization). This is in line with the assumption that the total fitness benefit of an escape mutation is greater than the benefit of a reversion (i.e. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e034" xlink:type="simple"/></inline-formula>).</p>
<table-wrap id="pcbi-1003899-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.t001</object-id><label>Table 1</label><caption>
<title>Parameters and variables of the (standard) model.</title>
</caption><alternatives><graphic id="pcbi-1003899-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">symbol</td>
<td align="left" rowspan="1" colspan="1">description</td>
<td align="left" rowspan="1" colspan="1">value</td>
<td align="left" rowspan="1" colspan="1">note</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e035" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">size of a hosts' binding repertoire</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e036" xlink:type="simple"/></inline-formula>; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e037" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(1)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e038" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">size of the union of all binding repertoires</td>
<td align="left" rowspan="1" colspan="1">300</td>
<td align="left" rowspan="1" colspan="1">(2)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e039" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">number of escape mutations</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e040" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e041" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">number of deleterious mutations</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e042" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e043" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">the total number of mutations</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e044" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e045" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">maximal <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e046" xlink:type="simple"/></inline-formula> virus load</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e047" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e048" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">escape rate in acute (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e049" xlink:type="simple"/></inline-formula>), asymptomatic (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e050" xlink:type="simple"/></inline-formula>) and AIDS (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e051" xlink:type="simple"/></inline-formula>) phase</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e052" xlink:type="simple"/></inline-formula>; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e053" xlink:type="simple"/></inline-formula>; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e054" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(3)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e055" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">reversion rate during disease phase <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e056" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e057" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e058" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(4)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e059" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e060" xlink:type="simple"/></inline-formula> virus load</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e061" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(5)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e062" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">decrease in <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e063" xlink:type="simple"/></inline-formula> virus load due to one immune response (without the fitness cost)</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e064" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(6)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e065" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">fitness cost of a mutation</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e066" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(6)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e067" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">infection rate during disease phase <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e068" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e069" xlink:type="simple"/></inline-formula>; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e070" xlink:type="simple"/></inline-formula>; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e071" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(7)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e072" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(mean) duration of disease phase <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e073" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e074" xlink:type="simple"/></inline-formula>; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e075" xlink:type="simple"/></inline-formula>; <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e076" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">(7)</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>Notes: (1) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e077" xlink:type="simple"/></inline-formula> is chosen larger than observed numbers of immune responses <xref ref-type="bibr" rid="pcbi.1003899-Liu1">[25]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Henn1">[27]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Liu2">[43]</xref>, since we predict that viruses have escape mutations at infection, and do not escape all CTL responses. <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e078" xlink:type="simple"/></inline-formula> is chosen to get reasonable variance in spVL, while limiting individuals with a very small binding repertoire. (2) About <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e079" xlink:type="simple"/></inline-formula> of all possible peptides from HIV-1's proteome of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e080" xlink:type="simple"/></inline-formula> a.a. (3) During the chronic phase, the escape rate slows down markedly <xref ref-type="bibr" rid="pcbi.1003899-Henn1">[27]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Asquith1">[60]</xref>, hence we take <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e081" xlink:type="simple"/></inline-formula>. The AIDS phase is sometimes preceded by escape from critical immune responses <xref ref-type="bibr" rid="pcbi.1003899-Nowak1">[75]</xref>, and modeling suggests that escape rate speeds up towards the late disease phase <xref ref-type="bibr" rid="pcbi.1003899-vanDeutekom1">[46]</xref>. Therefore we set <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e082" xlink:type="simple"/></inline-formula>. (4) Both reports on fast <xref ref-type="bibr" rid="pcbi.1003899-Fernandez1">[76]</xref> and very slow <xref ref-type="bibr" rid="pcbi.1003899-Fryer1">[77]</xref> reversion exist. We choose <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e083" xlink:type="simple"/></inline-formula> in the order of magnitude of the ratio fitness cost and escape benefit. (5) The model for virus load was taken from <xref ref-type="bibr" rid="pcbi.1003899-Schmid1">[35]</xref>. During the acute phase, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e084" xlink:type="simple"/></inline-formula> merely represents the virus fitness. (6) The magnitude <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e085" xlink:type="simple"/></inline-formula> is chosen to be in estimated ranges <xref ref-type="bibr" rid="pcbi.1003899-Kadolsky1">[31]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Kiepiela1">[32]</xref>. Since escape appears to be faster than reversion, we choose <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e086" xlink:type="simple"/></inline-formula>. Although several studies find that a CTL response to Gag gives a <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e087" xlink:type="simple"/></inline-formula> fold higher fitness cost than <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e088" xlink:type="simple"/></inline-formula> <xref ref-type="bibr" rid="pcbi.1003899-Goepfert1">[29]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Kiepiela1">[32]</xref>, we take <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e089" xlink:type="simple"/></inline-formula> as an average fitness cost. (7) The parameters <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e090" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e091" xlink:type="simple"/></inline-formula> were taken from <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>. The parameters for the Hill functions <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e092" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e093" xlink:type="simple"/></inline-formula> are: <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e094" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e095" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e096" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e097" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e098" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e099" xlink:type="simple"/></inline-formula>.</p></fn></table-wrap-foot></table-wrap>
<p>As mentioned earlier, a HIV-1 strain infecting a new host carries a history of mutations acquired in previous hosts <xref ref-type="bibr" rid="pcbi.1003899-Goepfert1">[29]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Leslie3">[38]</xref>. In the context of the new host, many of these mutations will not be beneficial. Some of them may be advantageous, because HLA molecules can share epitopes <xref ref-type="bibr" rid="pcbi.1003899-Rao1">[39]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Rao2">[40]</xref>, and individuals share HLA molecules. To keep our model simple, we assume that a random host's binding repertoire is a random subset of size <italic>k</italic> of the set of all <italic>n</italic> possible HIV-1 epitopes. In reality, HLA haplotypes, and hence binding repertoires, are less regularly distributed. However, our simpler distribution provides us with the advantage that we only have to keep track of the <italic>number</italic> of mutated peptides. Namely, when a host transmits a virus with <italic>e</italic> escape mutations and <italic>f</italic> deleterious mutations (denoted as an <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e100" xlink:type="simple"/></inline-formula>-virus), then in the secondary host the virus will have phenotype <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e101" xlink:type="simple"/></inline-formula> with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e102" xlink:type="simple"/></inline-formula>. We find the number of escape mutations <italic>e</italic>′ by choosing a new random binding repertoire of size <italic>k</italic>′. Since every peptide is part of the new binding repertoire with equal probability, the number of <italic>a priori</italic> escape mutations is drawn from the hypergeometric distribution (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e103" xlink:type="simple"/></inline-formula>). An example of how a virus' phenotype can differ between hosts is given in <xref ref-type="fig" rid="pcbi-1003899-g001">Figure 1</xref>. By default, we choose <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e104" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e105" xlink:type="simple"/></inline-formula> (see <xref ref-type="table" rid="pcbi-1003899-t001">Table 1</xref>), such that about 10% of HIV-1's peptides can serve as an epitope. The number <italic>k</italic> is chosen such that hosts have a realistic number of responses, also when many of the <italic>n</italic> peptides are mutated.</p>
<fig id="pcbi-1003899-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.g001</object-id><label>Figure 1</label><caption>
<title>The phenotype of a virus differs between hosts, depending on the hosts' HLA haplotype.</title>
<p>The virus in the figure has <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e106" xlink:type="simple"/></inline-formula> potential epitopes (the rectangles), of which <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e107" xlink:type="simple"/></inline-formula> have a mutation (the open rectangles). ‘pMHC’ denotes the peptide-HLA complex. (Host A) Host A's HLA molecules can not bind peptides 1 and 4 (neither the wild-type, nor the mutant), but they can bind the wild-type of peptides 2 and 5. Thus, the purple rectangles denote immune escape mutations and the green (dotted) rectangles represent deleterious mutations. Since peptides 2 and 5 are mutated, they are escape epitopes in host A. The HLA molecules of host A can bind peptides 3 and 6, and hence peptides 3 and 6 are the epitopes for host A. During the infectious lifetime of host A, epitopes 3 and 6 may escape, and the mutated peptides 1 and 4 may revert to the wild-type. (Host B) The HLA molecules of host B bind less peptides of the wild-type virus (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e108" xlink:type="simple"/></inline-formula>) than host A (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e109" xlink:type="simple"/></inline-formula>); host B mounts a single CTL response against peptide <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e110" xlink:type="simple"/></inline-formula>. The HLA molecules of host B can also bind the wild-type of peptide 1, but this peptide is mutated, and hence peptide 1 is an escape epitope in host B. During host B's infection, epitope 3 may escape, and peptides 2, 4 and 5 may revert to the wild-type.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.g001" position="float" xlink:type="simple"/></fig>
<p>We model the three phases of a HIV-1 infection based on Fraser et al. <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref> and Hollingsworth et al. <xref ref-type="bibr" rid="pcbi.1003899-Hollingsworth2">[41]</xref>. The acute phase has a fixed length <italic>D</italic><sub>1</sub>, and in this phase individuals have a fixed infectiousness <italic>β</italic><sub>1</sub>. After <italic>D</italic><sub>1</sub> years, the asymptomatic phase starts and infectiousness <italic>β</italic><sub>2</sub>(<italic>V</italic>) and the average length of the asymptomatic phase <italic>D</italic><sub>2</sub>(<italic>V</italic>) depend on the virus load <italic>V</italic>. The functions <italic>β</italic><sub>2</sub> and <italic>D</italic><sub>2</sub> are Hill functions with coefficients as estimated by Fraser et al. <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>. When the asymptomatic phase ends, the AIDS phase starts. This AIDS phase has, similar to the acute phase, a fixed length <italic>D</italic><sub>3</sub> and fixed infectiousness <italic>β</italic><sub>3</sub>. We do not incorporate any correction for serial monogamy on infectiousness.</p>
<p>As an illustration of the within-host model, we have simulated a large number of within-host processes for two different parameter settings (<xref ref-type="fig" rid="pcbi-1003899-g002">Figure 2</xref>). Stochasticity and host-heterogeneity cause large variation in the within-host evolution of the virus (the thin step-wise lines in <xref ref-type="fig" rid="pcbi-1003899-g002">Figure 2</xref>). As deleterious mutations are reverted and CTL responses are escaped, the virus load increases during the infection. If the mutation rate is high, almost all escapes happen during the acute phase of the infection. The cohort-average virus load (the heavy blue line in <xref ref-type="fig" rid="pcbi-1003899-g002">Figure 2</xref>, bottom panels) can then even decrease, since individuals with a high set-point develop AIDS more rapidly. When these fast progressors die, we exclude them from the calculation of the cohort's mean virus load. Notice that during the acute phase, the variable <italic>V</italic> does not reflect the peak virus loads observed in patients, but is merely a measure of the virus' fitness.</p>
<fig id="pcbi-1003899-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.g002</object-id><label>Figure 2</label><caption>
<title>The within-host model for immune escape for different mutation rates.</title>
<p>The graphs show the number of escape mutations (purple, top), the number of deleterious mutations (green, middle) and the virus load (blue, bottom). The mean number of mutations or virus load (the heavy lines) is based on <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e111" xlink:type="simple"/></inline-formula> simulations (the thin step-wise lines). The dots indicate that a host died. All infections start with a virus with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e112" xlink:type="simple"/></inline-formula> mutations. The acute phase of the infection (the first <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e113" xlink:type="simple"/></inline-formula>) is displayed magnified on the left of each plot, and a couple of simulations are highlighted in black. (A) The escape rate equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e114" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e115" xlink:type="simple"/></inline-formula>. (B) The escape rate equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e116" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e117" xlink:type="simple"/></inline-formula>. Other parameters are listed in <xref ref-type="table" rid="pcbi-1003899-t001">Table 1</xref>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.g002" position="float" xlink:type="simple"/></fig>
<p>For the between-host model, we explicitly model a population of infected individuals (of size <italic>I</italic>), and assume a frequency-dependent contact process with susceptibles <xref ref-type="bibr" rid="pcbi.1003899-Begon1">[42]</xref>. Super-infection and co-infection are ignored. We keep the total population size (<italic>N</italic>) constant, and only keep track of the susceptibles' number (<italic>S</italic>). Because of within-host evolution, an individual may transmit different viral strains during the course of an infection. When the virus load increases due to within-host adaptation, the infection rate also increases. We verified that a model with a non-constant population size does not give different results (not shown).</p>
<p>Since in our model the virus load can increase during the asymptomatic phase, we need to specify what we mean with set-point virus load. We define the spVL (in log<sub>10</sub> scale) as the geometric average of the log<sub>10</sub> virus loads in the asymptomatic phase, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e118" xlink:type="simple"/></inline-formula>, where the integral is taken over the chronic phase, which lasts <italic>L</italic> years, and <italic>V</italic>(<italic>t</italic>) denotes the virus load at time <italic>t</italic>. We often write <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e119" xlink:type="simple"/></inline-formula> to indicate the population-wide arithmetic average spVL. Bracket notation is also used for other population-wide averages.</p>
</sec><sec id="s2b">
<title>For realistic mutation rates, selection for immune escape dominates HIV-1 virulence evolution</title>
<p>When we choose the mutation rate low and run the agent-based model, the mean spVL converges to 4.52log<sub>10</sub> copies/ml; the value optimal for transmission (<xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3A</xref>). However, this takes many centuries, depending on the maximal virus load <italic>V</italic><sub>max</sub> and the initial number of mutations. By increasing the mutation rate, we make the evolutionary dynamics faster, but lose between-host adaptation (<xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3B</xref>). In fact, the mean spVL is approximately 1.3 log<sub>10</sub> copies/ml higher than 4.52. By keeping the mutation rate equally high, but lowering <italic>V</italic><sub>max</sub>, the HIV-1 quasi-species can be given a population-level fitness (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e120" xlink:type="simple"/></inline-formula>) that is about 17% higher than what is reached in <xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3B</xref>. Apparently, selection for spVL values that are optimal for transmission is overruled by within-host selection at high mutation rates.</p>
<fig id="pcbi-1003899-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.g003</object-id><label>Figure 3</label><caption>
<title>Two simulations of HIV-1 epidemics with two different mutation rates.</title>
<p>The parameters are as follows: The maximal virus load equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e121" xlink:type="simple"/></inline-formula>, and the population size equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e122" xlink:type="simple"/></inline-formula>. (A) The escape mutation rate in the acute phase equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e123" xlink:type="simple"/></inline-formula>. (B) The escape mutation rate in the acute phase equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e124" xlink:type="simple"/></inline-formula>. The other parameters are listed in <xref ref-type="table" rid="pcbi-1003899-t001">Table 1</xref>. The simulations were started with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e125" xlink:type="simple"/></inline-formula> infected individuals that were infected with a virus with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e126" xlink:type="simple"/></inline-formula> mutations. The heavy lines in the graph of the set-point (spVL) and the number of mutations (# mutations) denote the population-wide average, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e127" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e128" xlink:type="simple"/></inline-formula>, respectively. The light bands denote the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e129" xlink:type="simple"/></inline-formula> percentiles, and the dots indicate the spVL of the receiver of a transmission couple (spVL) and the number of mutations of the transmitted strain (# mutations). In the graphs of the spVL, the dashed black line indicates the mean set-point that maximizes the transmission potential of HIV-1.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.g003" position="float" xlink:type="simple"/></fig>
<p>Both simulations in <xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3</xref> are approaching different steady states. Thus, to investigate between-host adaptation further, we now look at the properties of the model in population-level steady state for many different parameter combinations (<xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4</xref>). To make the analysis computationally feasible, we stochastically approximate the next-generation matrix (NGM, see <xref ref-type="sec" rid="s4">Methods</xref>). We fix all parameters except for the mutation rates (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e130" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e131" xlink:type="simple"/></inline-formula>), and the maximum virus load (<italic>V</italic><sub>max</sub>). We keep the ratios <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e132" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e133" xlink:type="simple"/></inline-formula> between the mutation rates constant (see <xref ref-type="table" rid="pcbi-1003899-t001">Table 1</xref> for the parameters chosen). Apart from the standard model described above, we also consider two modifications that serve as controls. In the first control, we take out the effect of population-level selection for transmission. In the second control, we make the population homogeneous.</p>
<fig id="pcbi-1003899-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.g004</object-id><label>Figure 4</label><caption>
<title>Exploration of the parameter space in three scenarios.</title>
<p>The contours show the mean set-point virus load in the population-level equilibrium. The heavy black line indicates the graph of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e134" xlink:type="simple"/></inline-formula>, i.e., the value <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e135" xlink:type="simple"/></inline-formula> for which <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e136" xlink:type="simple"/></inline-formula> is optimal for transmission, given the mutation rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e137" xlink:type="simple"/></inline-formula>. (A) The standard model: A peaked TP and a heterogeneous host population. (B) Control 1: A flat TP and a heterogeneous population. (C) Control 2: A peaked TP and a homogeneous population.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.g004" position="float" xlink:type="simple"/></fig><sec id="s2b1">
<title>The standard model</title>
<p>In this model, the population is heterogeneous (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e138" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e139" xlink:type="simple"/></inline-formula>), and virulence and infectiousness are taken from Fraser et al. <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>, as described above. We refer to the resulting transmission potential (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e140" xlink:type="simple"/></inline-formula>) as ‘peaked’, because a single spVL value exists at which the number of secondary infections caused by one infected individual is maximal. Considering the population-level steady state for very high mutation rates can give us a measure of between-host adaptation. When we choose the escape rate in the acute phase (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e141" xlink:type="simple"/></inline-formula>) close to 10<sup>2</sup>y<sup>−1</sup>, the virus will escape all immune responses, and revert all deleterious mutations acquired in previous hosts, during the first few weeks of the infection (<xref ref-type="fig" rid="pcbi-1003899-g005">Figure 5B</xref>, black graphs). The population-average spVL will therefore tend to <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e142" xlink:type="simple"/></inline-formula>. In <xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4A</xref> this relation is visible when <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e143" xlink:type="simple"/></inline-formula> from the equidistant contours of the set-point in equilibrium. When we replace <italic>V</italic><sub>max</sub> by, say, <italic>V</italic><sub>max</sub>+0.5 and we observe that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e144" xlink:type="simple"/></inline-formula> changes into <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e145" xlink:type="simple"/></inline-formula>, then the virus is not capable of between-host adaptation. In our parameter space exploration, this isometric dependence of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e146" xlink:type="simple"/></inline-formula> on <italic>V</italic><sub>max</sub> can not only be observed for unrealistically high, but also for intermediate mutation rates.</p>
<fig id="pcbi-1003899-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.g005</object-id><label>Figure 5</label><caption>
<title>Heritability of set-point and the number of mutations during the acute phase.</title>
<p>(A) The average number of escape (solid) and deleterious (dashed) mutations at the end of the acute phase for different <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e147" xlink:type="simple"/></inline-formula>. The resulting graph is barely dependent on <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e148" xlink:type="simple"/></inline-formula> within the range <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e149" xlink:type="simple"/></inline-formula> (not shown). However, we choose <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e150" xlink:type="simple"/></inline-formula> such that the mean set-point virus load (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e151" xlink:type="simple"/></inline-formula>) equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e152" xlink:type="simple"/></inline-formula>, cf. the blue, dashed line in panel D (this also holds for panels B and C). The gray band indicates the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e153" xlink:type="simple"/></inline-formula> percentiles for the number of escape mutations in the acute phase. (B) The mean fraction of immune responses (solid) and deleterious mutations (dashed) that remain after the acute phase. The resulting graph is barely dependent on <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e154" xlink:type="simple"/></inline-formula> within the range <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e155" xlink:type="simple"/></inline-formula> (not shown). (C) Heritability as a function of the mutation rate (upper red line). The black line below corresponds to the contribution of the immunological footprint to heritability, as estimated with the SEM. (D) Heritability of set-point virus load for different combinations of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e156" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e157" xlink:type="simple"/></inline-formula> for the standard model in steady state. The blue, dashed line indicates the contour where the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e158" xlink:type="simple"/></inline-formula> equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e159" xlink:type="simple"/></inline-formula>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.g005" position="float" xlink:type="simple"/></fig>
<p>Notice that our parameter space exploration can be regarded as a sensitivity analysis. For a fixed escape rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e160" xlink:type="simple"/></inline-formula>, a value <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e161" xlink:type="simple"/></inline-formula> exists such that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e162" xlink:type="simple"/></inline-formula> is optimal for transmission. By varying <italic>V</italic><sub>max</sub> around the value <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e163" xlink:type="simple"/></inline-formula>, we can study the sensitivity of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e164" xlink:type="simple"/></inline-formula> with respect to <italic>V</italic><sub>max</sub>. In <xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4</xref> the graphs of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e165" xlink:type="simple"/></inline-formula> are given by heavy black lines.</p>
<p>A different picture emerges for low mutation rates (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e166" xlink:type="simple"/></inline-formula>). The contours are no longer equidistant, indicating that the steady state, the result of mutation and selection, is less sensitive to changes in <italic>V</italic><sub>max</sub>. The absence of <italic>V</italic><sub>max</sub>-sensitivity is most noticeable when <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e167" xlink:type="simple"/></inline-formula>. This suggests that the virus is able to adapt on the level of the population (between-host adaptation). We will confirm this using Control 1 below. As mentioned before (<xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3</xref>), between-host adaptation takes many centuries for small mutation rates. The within-host process for this parameter regime is extremely slow.</p>
<p>By considering the number of escape mutations in the acute phase, we can get insight into what parameter regime is realistic for HIV-1. Several studies show that the number of escape mutations in the first months after infection varies among patients, and lies between 1 and 10 <xref ref-type="bibr" rid="pcbi.1003899-Liu1">[25]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Henn1">[27]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Liu2">[43]</xref>. This suggests that for escape rates <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e168" xlink:type="simple"/></inline-formula> to be considered realistic, they must be in the range 10<sup>−1</sup> to 10<sup>1</sup>y<sup>−1</sup> (see <xref ref-type="fig" rid="pcbi-1003899-g005">Figure 5A</xref>). For these intermediate mutation rates, we see a strong effect of host-heterogeneity. Host-heterogeneity and subsequent infections that require new escape mutations, account for the accumulation of deleterious mutations, since deleterious mutations are not lost at a fast enough rate. The virus' inadequacy to fully adapt to individuals during infection decreases the within-host virus load. We will further justify this with Control 2 below. However, the lack of perfect adaptation to individuals' immune systems does not noticeably facilitate between-host adaptation. In the regime of realistic CTL escape rates (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e169" xlink:type="simple"/></inline-formula>), spVL evolution is not driven by the life history trade-off, as can be seen from the isometric relation between <italic>V</italic><sub>max</sub> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e170" xlink:type="simple"/></inline-formula> (<xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4A</xref>).</p>
</sec><sec id="s2b2">
<title>Control 1, eliminating population-level selection</title>
<p>By comparing the standard model with a model where no between-host adaptation is possible, we can study the impact of the peaked transmission potential. We eliminate selection for transmission by scaling each host's infectiousness such that the expected number of secondary infections during an entire infectious lifetime equals the same constant for all individuals. The transmission potential will therefore be ‘flat’. To make this precise, let <italic>β</italic>(<italic>t</italic>) denote an individuals infection rate at time <italic>t</italic> (depending on disease phase or virus load). We now want to make sure that each individual is expected to infect 2 new individuals (in a fully susceptible population). To achieve this, we replace <italic>β</italic>(<italic>t</italic>) with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e171" xlink:type="simple"/></inline-formula>. Here <italic>t</italic><sub>infection</sub> and <italic>t</italic><sub>death</sub> denote the time of infection and death, respectively. Notice that we do allow for variation in virulence; the length of the infectious period (<italic>t</italic><sub>death</sub>−<italic>t</italic><sub>infection</sub>) is equally dependent on virus load as in the standard model. Hence, we eliminate selection for transmission without altering the within-host process.</p>
<p><xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4B</xref> shows the mean spVL in steady state for the flat TP and a heterogeneous population (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e172" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e173" xlink:type="simple"/></inline-formula>). The evolutionary outcomes for control 1 and the standard model are nearly identical when the escape rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e174" xlink:type="simple"/></inline-formula>. This confirms that the virus is not capable of between-host adaptation when mutation rates allow for a realistic number of escape mutations during an infection. For extremely low mutation rates (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e175" xlink:type="simple"/></inline-formula>), we see a difference between the model with a flat and a peaked TP, confirming that between-host adaptation relies on low mutation rates.</p>
<p>In the slow mutation regime, optimizing the life-history trade-off can be accomplished in two ways. If the virus were to experience a flat transmission potential, then a quasi-species' spVL distribution and the number of accumulated mutations would only be determined by the rate of escape and reversion, and the heterogeneity of the host population. If the same species starts evolving under the influence of a peaked transmission potential, then the number of mutations might either decrease, resulting in a lower fitness cost, and a higher <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e176" xlink:type="simple"/></inline-formula> (e.g., when <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e177" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e178" xlink:type="simple"/></inline-formula>), or the number of mutations might increase, resulting in a lower <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e179" xlink:type="simple"/></inline-formula> (e.g., when <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e180" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e181" xlink:type="simple"/></inline-formula>). Notice that mutations always arise as CTL escapes in an individual, but that such a mutation is most often deleterious in the other hosts.</p>
</sec><sec id="s2b3">
<title>Control 2, the homogeneous case</title>
<p>The effect of HLA-polymorphism can be studied by considering a model without host-heterogeneity. In the models with heterogeneous host populations, we assigned upon infection of a new individual a random binding repertoire, i.e., a random subset of size <italic>k</italic> of the virus' <italic>n</italic> potential epitopes. For this control, we assign to every host exactly the same binding repertoire. As a consequence, escape mutations remain beneficial after infection of a new host. Notice that in our model deleterious mutations always originate from escape mutations in earlier hosts with a non-identical binding repertoire. Therefore, deleterious mutations are purged from the population.</p>
<p><xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4C</xref> shows the mean spVL in steady state in case of a homogeneous host population (with a peaked TP). For a wide range of mutation rates, the virus manages to escape all immune responses. As a consequence, there is no room for population-level adaptation with respect to transmission, which is visible from the equidistant <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e182" xlink:type="simple"/></inline-formula>-contours, and the isometric relation between <italic>V</italic><sub>max</sub> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e183" xlink:type="simple"/></inline-formula>. If we compare <xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4A and C</xref> at intermediate mutation rates (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e184" xlink:type="simple"/></inline-formula>), we indeed see that host-heterogeneity lowers the set-point drastically.</p>
<p>For small mutation rates (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e185" xlink:type="simple"/></inline-formula>) we observe a threshold, which depends on <italic>V</italic><sub>max</sub> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e186" xlink:type="simple"/></inline-formula>. For mutation rates below this threshold, viruses evolve that do not escape all immune responses. When the mutation rate is small enough, escape mutations are rare. Viral strains that do escape yet another immune response will establish a higher set-point virus load. These escape mutants are then out-competed on the population level by strains that are better recognized by CTLs, because the life-history trade-off favors a lower set-point.</p>
<p>The above mentioned threshold can be better understood by studying the NGM. The stochastic model can be simplified so that a mathematical analysis is possible. The threshold for the homogeneous model can be described in terms of the eigenvalues of the NGM and is caused by a transcritical bifurcation (see <xref ref-type="sec" rid="s4">Methods</xref>). The heavy black line in <xref ref-type="fig" rid="pcbi-1003899-g006">Figure 6</xref>, which we find with the mathematical analysis, gives the location of the bifurcation. This line separates the parameter space into a region where between-host adaptation is possible, and where it is not. The line coincides with the apparent threshold that can be observed in <xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4B</xref>.</p>
<fig id="pcbi-1003899-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.g006</object-id><label>Figure 6</label><caption>
<title>The bifurcation in the homogeneous model.</title>
<p>For each <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e187" xlink:type="simple"/></inline-formula> a thin gray line indicates the curve <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e188" xlink:type="simple"/></inline-formula>. The heavy black line separates the region of the parameter space (between-host adaptation) where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e189" xlink:type="simple"/></inline-formula> for all <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e190" xlink:type="simple"/></inline-formula>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.g006" position="float" xlink:type="simple"/></fig></sec></sec><sec id="s2c">
<title>Immune escape causes heritability of set-point virus load</title>
<p>Between-host adaptation is only possible if spVL is inherited from one person to the next. If the speed of within-host adaptation is intermediate or fast, our model does not predict population-level adaptation for transmission. Here we show that the absence of between-host adaptation is not due to lack of spVL heritability (<italic>h</italic><sup>2</sup>, see <xref ref-type="sec" rid="s4">Methods</xref>). To this end, we compute heritability during an epidemic (see <xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3</xref>, bottom panels), and in the steady state of the (standard) model for many different parameter combinations (see <xref ref-type="fig" rid="pcbi-1003899-g005">Figure 5C</xref>).</p>
<p>During a simulated epidemic, we use all transmissions that take place within a time span of a year to compute heritability. This means that the sample size for computing heritability equals the (yearly) incidence. The median incidence in the simulation with a low mutation rate (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e191" xlink:type="simple"/></inline-formula>, <xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3B</xref>) equals 2335 yearly infections (2.5th, 97.5th percentiles: [1839,4085]). For the simulation with a faster mutation rate (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e192" xlink:type="simple"/></inline-formula>, <xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3A</xref>), more virulent viruses evolve, and the median incidence equals 3209 infections per year (2.5th, 97.5th percentiles: [241,3586]). Even with these large sample sizes, heritability fluctuates substantially. In <xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3B</xref> the median of <italic>h</italic><sup>2</sup> is 3.12% (2.5th, 97.5th percentiles: [−1.31,8.29]), and in <xref ref-type="fig" rid="pcbi-1003899-g003">Figure 3A</xref> the median of <italic>h</italic><sup>2</sup> is 17.1% (2.5th, 97.5th percentiles: [10.8,21.8]). The rapid fluctuation in <italic>h</italic><sup>2</sup> might explain why different experimental studies to HIV-1 spVL heritability that use transmission couples <xref ref-type="bibr" rid="pcbi.1003899-Hollingsworth1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Yue1">[11]</xref>–<xref ref-type="bibr" rid="pcbi.1003899-Tang1">[14]</xref> often give quite varying results [cf. 9]. The NGM approach allowed us to produce an even larger number of transmission couples, and hence, to estimate heritability more accurately. Overall, heritability lies between 0% and 30%, and is <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e193" xlink:type="simple"/></inline-formula> for realistic parameter combinations.</p>
<p>In our model, one can think of two mechanisms that cause heritability. The first mechanism applies when mutation rates are not too high. If variation in the number of mutations exists and the mutation rate is low, the spVL of transmitting and recipient hosts are correlated, although this correlation will not be perfect due to the variation in the breadth of the immune response (<italic>k</italic>). If the mutation rate increases, viruses adapt to their host more rapidly and, according to this first mechanism, the correlation vanishes.</p>
<p>The second mechanism is related to transmission of crippled viruses. If a host controls the infection well because of a broad immune response, the virus will escape more CTL responses and, when transmitted, becomes crippled in the average new host. In the primary, controlling host, the set-point virus load is low due to good initial immune responses and the virus' fitness cost of escape, and in the average secondary host the virus load will again be low due to the high number of deleterious mutations. <italic>Vice versa</italic>, in hosts with a narrow immune response, transmitted strains will have few new escape mutations and this will lead to few deleterious mutations in the recipient.</p>
<p>We can most clearly see the effect of the second mechanism when both mutation rate and <italic>V</italic><sub>max</sub> are high (the contour <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e194" xlink:type="simple"/></inline-formula> in <xref ref-type="fig" rid="pcbi-1003899-g005">Figure 5C</xref>). In this part of the parameter space, most immune responses are escaped in the acute phase (cf. the solid graph in <xref ref-type="fig" rid="pcbi-1003899-g005">Figure 5B</xref>). Rapid escape causes variation in the number of deleterious mutations in the transmitted virus, because the size of the binding repertoire (<italic>k</italic>) varies among individuals. However, when <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e195" xlink:type="simple"/></inline-formula>, not all deleterious mutations can be reverted in the acute phase (cf. the dashed graph in <xref ref-type="fig" rid="pcbi-1003899-g005">Figure 5B</xref>). For high <italic>V</italic><sub>max</sub>, the asymptomatic phase is short, resulting in few reversions during this phase and a ‘footprint’ of the transmitting host's immune responses on the receiving host's spVL <xref ref-type="bibr" rid="pcbi.1003899-Yue1">[11]</xref>. Notice that the second mechanism does depend on the reasonable assumption that reversion is a slower process than escape (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e196" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e197" xlink:type="simple"/></inline-formula>, not shown), and that the size of the binding repertoire (<italic>k</italic>) differs between individuals.</p>
<p>As the above evidence for the second mechanism—or ‘footprint effect’ as we like to call it—is only circumstantial, a quantification of this mechanism is needed. To quantify the footprint effect we analyze the simulations using a structural equation model (SEM). The model estimates heritability, and takes the fitness costs (<italic>m</italic> = <italic>e</italic>+<italic>f</italic>) and breadth of the immune response (<italic>k</italic>) into account. Heritability of spVL is the sum of two effects; one mediated by viral fitness, and the other by the breadth of the immune response of the transmitting host. <xref ref-type="fig" rid="pcbi-1003899-g007">Figure 7</xref> shows a graphical representation of the model, and details of the analyses are given in the <xref ref-type="sec" rid="s4">Methods</xref> section.</p>
<fig id="pcbi-1003899-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.g007</object-id><label>Figure 7</label><caption>
<title>The structural equation model (SEM) used for quantifying the immunological footprint.</title>
<p>Shown is a directed, acyclic graph (DAG) representing the SEM. The arrows indicate dependencies between the variables. The numbers above the arrows are the fitted weights (all highly significant: <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e198" xlink:type="simple"/></inline-formula>), and the size of these weights is also represented by the thickness of the arrows. The data for this example comes from a simulation of the standard model, with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e199" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e200" xlink:type="simple"/></inline-formula>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.g007" position="float" xlink:type="simple"/></fig>
<p>For realistic parameter values, approximately half of the observed heritability is due to the footprint effect (<xref ref-type="fig" rid="pcbi-1003899-g005">Figure 5C</xref>). When we lower the rate of escape, the footprint effect, and therefore also the heritability, decreases. On the contrary, when within-host evolution is extremely fast, almost all of the heritability is due to the footprint effect, although the total heritability decreases.</p>
</sec><sec id="s2d">
<title>Host heterogeneity and spVL heritability: A model-based prediction</title>
<p>Our model predicts that heritability of the set-point virus load and host-heterogeneity are related. When within-host evolution is fast enough, approximately half of the observed heritability may be explained by the immunological footprint. Also, when we lower heterogeneity in our model, heritability decreases.</p>
<p>An intuitive measure for heterogeneity in the host population is the expected similarity of hosts’ binding repertoires. This tells us how much adaptation to one host remains beneficial in the next. As a measure of the similarity of two binding repertoires <italic>K</italic><sub>1</sub> and <italic>K</italic><sub>2</sub> (of size <italic>k</italic><sub>1</sub> and <italic>k</italic><sub>2</sub>, respectively) we use the Jaccard index <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e201" xlink:type="simple"/></inline-formula>, the overlap between binding repertoires, divided by the the number of (wild-type) epitopes that at least one of the hosts can recognize.</p>
<p><xref ref-type="fig" rid="pcbi-1003899-g008">Figure 8A</xref> shows the relation between the expected similarity between hosts (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e202" xlink:type="simple"/></inline-formula>) and the heritability of the set-point (<italic>h</italic><sup>2</sup>). We modulated heterogeneity by varying <italic>n</italic>, the total number of potential epitopes, between 30 and 300, corresponding to low and high host-heterogeneity, respectively. The mutation rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e203" xlink:type="simple"/></inline-formula> equals 3y<sup>−1</sup>, such that the number of escape mutations during the acute phase lies within a realistic range. The figure shows that heritability indeed decreases when the population becomes more homogeneous, which indicates that high heritability relies on host-heterogeneity.</p>
<fig id="pcbi-1003899-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.g008</object-id><label>Figure 8</label><caption>
<title>Host-heterogeneity and heritability.</title>
<p>(A) The panel shows a contour plot of heritability (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e204" xlink:type="simple"/></inline-formula>, gray lines, red/yellow faces) as a function of the maximal virus load (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e205" xlink:type="simple"/></inline-formula>) and the expected similarity between binding repertoires (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e206" xlink:type="simple"/></inline-formula>). On top of the heritability contour plot, the blue lines indicate the contours of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e207" xlink:type="simple"/></inline-formula>. The heavy blue contour corresponds to the transmission-optimal <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e208" xlink:type="simple"/></inline-formula>. (B) Distributions of the overlap between pairs of binding repertoires. The black bars correspond to European HLA-haplotypes and a clade B virus (sampled in the Netherlands). The gray bars correspond to Sub-Saharan HLA-haplotypes and a clade C virus (sampled in South Africa). The distributions were simulated by sampling a <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e209" xlink:type="simple"/></inline-formula> HLA-haplotype pairs. (C) Statistics on the sampled distributions as in panel B. The left panel shows the medians of the similarity distributions for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e210" xlink:type="simple"/></inline-formula> strains representative of clade B (black dots) and clade C (gray dots). The difference is significant (Mann-Withney <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e211" xlink:type="simple"/></inline-formula>-test, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e212" xlink:type="simple"/></inline-formula>, *). The right panel depicts the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e213" xlink:type="simple"/></inline-formula>-statistic for all clade B and clade C pairs. The mean of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e214" xlink:type="simple"/></inline-formula>-statistics is significantly larger than <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e215" xlink:type="simple"/></inline-formula> (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e216" xlink:type="simple"/></inline-formula>-test <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e217" xlink:type="simple"/></inline-formula>, ***).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.g008" position="float" xlink:type="simple"/></fig>
<p>HLA-heterogeneity differs between human populations. If our model prediction holds, then this variation could affect the heritability of the set-point measured in these populations. An unpublished study by Hodcroft et al. <xref ref-type="bibr" rid="pcbi.1003899-Hodcroft2">[44]</xref>, shows that heritability in measured for HIV-1 clade C in a Sub-Saharan African population is higher than heritability for HIV-1 clade B in a European cohort <xref ref-type="bibr" rid="pcbi.1003899-Hodcroft1">[10]</xref> (30% vs. 5.7%). Keeping our model in mind, we are able to understand this, if the European population with respect to clade B, is less heterogeneous than the Sub-Saharan population with respect to clade C.</p>
<p>Using the peptide-MHC binding predictor NetMHCpan <xref ref-type="bibr" rid="pcbi.1003899-Hoof1">[45]</xref>, we compared the two populations and circulating viruses (see <xref ref-type="sec" rid="s4">Methods</xref>). Again, we measured heterogeneity in terms of similarity between binding repertoires. We sampled from the HLA-haplotype distributions of the European and Sub-Saharan populations, and calculated how similarity (again measured in terms of the Jaccard index) within these populations is distributed. <xref ref-type="fig" rid="pcbi-1003899-g008">Figure 8B</xref> shows two of these distributions. The black bars correspond to the European population, and the gray bars to the Sub-Saharan population. Although small, these populations do show a difference in heterogeneity: The Sub-Saharan population is more heterogeneous than the European population, as European binding repertoires tend to be more similar. The difference in heterogeneity is statistically significant (see <xref ref-type="sec" rid="s4">Methods</xref> and <xref ref-type="fig" rid="pcbi-1003899-g008">Figure 8C</xref>).</p>
</sec></sec><sec id="s3">
<title>Discussion</title>
<p>In this paper, we model HIV-1 transmission and within-host adaptation by means of immune escape in a HLA-heterogeneous host population. In comparison to what data suggests, we do not find that HIV-1's life history trade-off determines or influences spVL evolution. For realistic mutation rates, the evolutionary outcome is mostly determined by within-host selection for escape and reversion. Without HLA-heterogeneity, viruses would evolve to be within-host optimal in every host. Due to HLA-polymorphism, however, deleterious mutations accumulate, and the environment changes at each transmission. This causes virulence to evolve to intermediate levels for most hosts. Incomplete adaptation at the individual level is not exploited by the virus in order to improve it's transmission potential. Although set-point virus loads are expected to be lower in a heterogeneous population, spVL evolution remains short-sighted. As we will point out below, our model is limited in the sense that we only incorporate immune escape and reversion as a means for within-host and between-host adaptation. Nevertheless, since population-level adaptation does occur when within-host adaptation is slow, the model's limitations do not necessarily revoke our conclusions.</p>
<p>In our model, we do find that spVL is heritable, even when the mutation rate is high. spVL heritability is needed for between-host adaptation. However, for realistic mutation rates, high heritability, as measured using transmission couples, is over-estimated; it mostly results from a ‘footprint’ left by the transmitter's immune system on the receiver's spVL. This novel explanation calls the validity of the use of high heritability as support for between-host adaptation in question. During real HIV-1 infections, immune escape sometimes requires compensatory mutations. Such escape variants need more time to revert to the wild-type in hosts lacking the escaped CTL response <xref ref-type="bibr" rid="pcbi.1003899-vanDeutekom1">[46]</xref>. Such a mechanism is not incorporated in our model, but is likely to cause even higher heritability compared to what we find. Given previous results on the effects of transmitted CTL escape mutations on a receiver's virus load <xref ref-type="bibr" rid="pcbi.1003899-Goepfert1">[29]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Leslie2">[33]</xref>, and the sharing of HLA alleles <xref ref-type="bibr" rid="pcbi.1003899-Yue1">[11]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Dorak1">[47]</xref>, we think the footprint effect provides a sound explanation for the experimentally observed high heritability of the set-point. Importantly, if this explanation were to be found true, and if spVL evolution and heritability are indeed strongly influenced by CTL escape, reversion and compensatory mutations, finding SNPs in HIV-1's genome that control spVL might be a fool's errand, unless this pursuit would be restricted to known CTL-epitope sites.</p>
<p>Our claims concerning the footprint effect, and the dependency of heritability on host-heterogeneity are not just speculative. We show that the model can make testable predictions, and we give an example of how such a test can be performed, i.e., by comparing host-heterogeneity in different human populations. In our example, we compared Sub-Saharan and European populations with respect to the viruses circulating in these populations, and showed that host-heterogeneity is higher in the African population, which is consistent with our novel explanation, and estimates of the heritability in these populations. Of course, we would not suggest that this isolated finding is evidence for the footprint effect, although we do want to stress that heritability estimates are expected to be correlated with host heterogeneity. Moreover, the heritability estimates that were used in this example were obtained using a phylogenetic analysis <xref ref-type="bibr" rid="pcbi.1003899-Hodcroft1">[10]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Hodcroft2">[44]</xref>, while our explanation only holds for studies that use transmission couples. In future work, we plan to investigate whether an immunological footprint can also affect heritability that has been estimated using phylogenies or pedigrees.</p>
<p>Intuitively, the fact that within-host adaptation overrules between-host adaptation can be understood by considering that many viral generations separate the founding virus and a transmitted strain, while transmission only takes one generation. In the homogeneous model, this results in full within-host adaptation (throughout the population all epitopes are escaped), except when within-host adaptation is extremely slow. This result was also shown recently by Lythgoe et al. <xref ref-type="bibr" rid="pcbi.1003899-Lythgoe1">[21]</xref>.</p>
<p>The intuition mentioned above works best for homogeneous populations. Adaptations to a primary host are beneficial again in a secondary host, and if within-host adaptation is fast, this leads to population-wide within-host adaptation and not between-host adaptation. This part of the intuition fails for a heterogeneous host population, where within-host adaptations in the form of immune escapes, are most likely not beneficial in the next host. Therefore, one could argue that homogeneity obstructs between-host adaptation. Here, we attempt to remove that obstruction by adding host-heterogeneity to a multi-level HIV-1 model. We find that in a heterogeneous population, HIV-1 also fails to evolve a mean spVL that maximizes the transmission potential, as shown by our sensitivity analysis and controls. Of course, when we make within-host adaptation trivial by choosing a very low mutation rate, population-level adaptation occurs.</p>
<p>Apparently, host-heterogeneity does not solve the within- versus between-host adaptation paradox. Our models tell us that within-host adaptation overrules between-host adaptation, and yet HIV-1 appears to have adapted with respect to the life history trade-off <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>, or at least is evolving its mean spVL towards the value that maximizes the transmission potential <xref ref-type="bibr" rid="pcbi.1003899-Herbeck1">[48]</xref>. Several mechanisms that can serve as a solution for the paradoxical observation have been proposed <xref ref-type="bibr" rid="pcbi.1003899-Lythgoe2">[49]</xref>–<xref ref-type="bibr" rid="pcbi.1003899-Fraser2">[51]</xref>.</p>
<p>One of these mechanisms is referred to as ‘store and retrieve’ <xref ref-type="bibr" rid="pcbi.1003899-Lythgoe2">[49]</xref>. It is hypothesized that latently infected memory CD4<sup>+</sup> cells occasionally produce virus, and that these virions are preferentially transmitted. Preferential transmission is backed up by the observation that evolutionary rates are higher at the within-host than at the between-host level <xref ref-type="bibr" rid="pcbi.1003899-Alizon2">[52]</xref>, and recently by a very interesting study into HIV-1's transmission bottleneck <xref ref-type="bibr" rid="pcbi.1003899-Carlson1">[53]</xref>. However, transmission of CTL escape mutants within transmission couples <xref ref-type="bibr" rid="pcbi.1003899-Goepfert1">[29]</xref>, and even the spread of CTL escape mutants through populations has been observed <xref ref-type="bibr" rid="pcbi.1003899-Leslie3">[38]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Moore1">[54]</xref>–<xref ref-type="bibr" rid="pcbi.1003899-Schellens1">[57]</xref>. These observations indicates that ‘store and retrieve’ is not absolute, and in order for this mechanism to solve the paradox, we expect it to rely on getting the population-level evolutionary rate below a threshold; one which may not be reached. This premise could limit the robustness of the ‘store and retrieve’ model. Furthermore, when the population-level evolutionary rate is slowed down because of a mechanism like ‘store and retrieve’, the rate of between-host adaptation is also decreased, which could conflict with the short time scales at which adaptation must have been taking place for HIV-1 <xref ref-type="bibr" rid="pcbi.1003899-Shirreff1">[18]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Sharp1">[20]</xref>.</p>
<p>Another possible mechanism is a heritable viral trait that influences spVL, but that is not under within-host selection. This was recently examined by Hool et al. <xref ref-type="bibr" rid="pcbi.1003899-Hool1">[50]</xref>. An example of such a trait could be target cell activation rate <xref ref-type="bibr" rid="pcbi.1003899-Bartha1">[58]</xref>, <xref ref-type="bibr" rid="pcbi.1003899-Sanjun1">[59]</xref>. In short, if a viral trait influences target cell activation, and a mutant strain manages to increase the activation rate, then this additional activation is a ‘common good’ for the entire within-host viral population (activated cells produce more virions). Hence, the mutant does not have an advantage and will not be preferentially selected. Drift creates within-host variation in activation rate, and the transmission bottleneck leads to variation of the target cell activation rate at the population-level. This hypothesis could be challenged by other traits that affect spVL, since these may still be under within-host selection, and are likely to interfere with the within-host neutral one.</p>
<p>We finish with a novel suggestion for solving the paradox, one which is based on our modeling formalism, and was recently also put forward by Fraser et al. <xref ref-type="bibr" rid="pcbi.1003899-Fraser2">[51]</xref>. One point of criticism on our model could be that we limit the evolutionary capabilities of our <italic>in-silico</italic> viruses. Strains can only evolve their number of deleterious mutations in order to approach population-level favorable spVLs. Unfortunately, in the current framework, it is not sensible to allow for mutations in other parameters, in particular <italic>V</italic><sub>max</sub>, since then <italic>V</italic><sub>max</sub> would only increase during within-host evolution, and hence, during the course of the epidemic. This is because we assume that no two strains simultaneously reside a single host, and that mutants with a higher fitness go to fixation rapidly. In reality, fixation of mutants within a host can take a considerable amount of time <xref ref-type="bibr" rid="pcbi.1003899-Asquith1">[60]</xref>.</p>
<p>An obvious—but technically challenging—fix for this problem is to abandon the assumption that the within-host evolutionary dynamics is memoryless, and allow for multiple mutants to compete for fixation, i.e., allow for clonal interference <xref ref-type="bibr" rid="pcbi.1003899-Kessinger1">[61]</xref>–<xref ref-type="bibr" rid="pcbi.1003899-Pandit1">[65]</xref>. These mutants can then carry negative fitness effects (e.g., <italic>V</italic><sub>max</sub> decreasing mutations) along with beneficial escape mutations or reversions (genetic hitchhiking). Additionally, mutants with a small <italic>V</italic><sub>max</sub> increasing effect, but that are otherwise equal to the wild-type, may have a long fixation time and can easily be out-competed by, e.g., escape mutants. This makes within-host <italic>V</italic><sub>max</sub> evolution more selectively neutral, and hence more sensible in our model. In future work, we aim to test if these speculations are valid, and whether a more detailed within-host fitness and selection model can unify within-host evolution and population-level adaptation.</p>
</sec><sec id="s4" sec-type="methods">
<title>Methods</title>
<p>Our full model is a two-level individual and discrete-event based simulation, based on the Sellke construction <xref ref-type="bibr" rid="pcbi.1003899-Sellke1">[66]</xref>. The Sellke construction generalizes the Gillespie algorithm, by allowing for non-exponentially distributed waiting times. We need this generalization to allow for realistic non-exponential distributions of the length of the asymptomatic phase, as estimated earlier <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>. Events in our simulation occur at particular points in time, which determines the order of these events. If an event takes place, this may alter the state (e.g. the number of susceptible individuals, or the virulence) and this influences the moments and order at which future events take place. The model was coded in C++ and analyzed using Python and R. The code has been made available as an electronic supplement (<xref ref-type="supplementary-material" rid="pcbi.1003899.s001">File S1</xref>).</p>
<p>The agents and events that are described explicitly in our model are listed in <xref ref-type="table" rid="pcbi-1003899-t002">Table 2</xref>. In order to determine what the next event will be and when it takes place, we need to know how to compute waiting times.</p>
<table-wrap id="pcbi-1003899-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.t002</object-id><label>Table 2</label><caption>
<title>Agents and events in the model.</title>
</caption><alternatives><graphic id="pcbi-1003899-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">Agent</td>
<td align="left" rowspan="1" colspan="1">Events</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>within-host level</italic></td>
<td align="left" rowspan="1" colspan="1">virus</td>
<td align="left" rowspan="1" colspan="1">escape mutation, reversion</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">disease phase</td>
<td align="left" rowspan="1" colspan="1">transition to next disease phase</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><italic>between-host level</italic></td>
<td align="left" rowspan="1" colspan="1">host</td>
<td align="left" rowspan="1" colspan="1">transmission, death</td>
</tr>
</tbody>
</table>
</alternatives></table-wrap><sec id="s4a">
<title>Waiting times</title>
<p>In general, whenever a new event <italic>E</italic> is created during the simulation at time <italic>t</italic>, the exact moment when <italic>E</italic> will take place is unknown. Therefore, we assign to <italic>E</italic> a threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e218" xlink:type="simple"/></inline-formula> and a load <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e219" xlink:type="simple"/></inline-formula>. The threshold <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e220" xlink:type="simple"/></inline-formula> is sampled from some probability distribution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e221" xlink:type="simple"/></inline-formula> with non-negative support and mean 1. We first compute the waiting time <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e222" xlink:type="simple"/></inline-formula>, while conditioning on <italic>E</italic> being the first event to take place: <disp-formula id="pcbi.1003899.e223"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e223" xlink:type="simple"/></disp-formula></p>
<p>Here, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e224" xlink:type="simple"/></inline-formula> is the ‘rate’ or ‘hazard’ at which <italic>E</italic> takes place, which can depend on time. Notice that the (conditional) waiting time <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e225" xlink:type="simple"/></inline-formula> could be infinite (e.g., when the number of susceptibles equals zero, the first event to take place can never be a transmission).</p>
<p>When we perform this computation for all future events <italic>E</italic>, we find the event <italic>F</italic> that must take place first, and also the time at which it takes place, i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e226" xlink:type="simple"/></inline-formula>. We then perform the following steps: First, we update the time <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e227" xlink:type="simple"/></inline-formula>. Then, for all future events <italic>E</italic>, we update the load <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e228" xlink:type="simple"/></inline-formula> as follows: <disp-formula id="pcbi.1003899.e229"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e229" xlink:type="simple"/></disp-formula></p>
<p>Finally, we let the event <italic>F</italic> act on the current state and remove <italic>F</italic> from our event list. For instance, if <italic>F</italic> happens to be a transmission event, we should initiate a new host and decrease the number of susceptible individuals. Additionally, new transmission events should be created for the transmitter and recipient. Hereafter, we re-compute the waiting times <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e230" xlink:type="simple"/></inline-formula> for all events <italic>E</italic> and repeat the above steps.</p>
<p>In most cases, the computation of <italic>w</italic><sub>E</sub> and the updating of <italic>α</italic><sub>E</sub> is simple. For instance, if <italic>E</italic> is a reversion event and <italic>f</italic>&gt;0, then <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e231" xlink:type="simple"/></inline-formula>. For updating the load, we replace <italic>α</italic><sub>E</sub> with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e232" xlink:type="simple"/></inline-formula>. A transmission event requires more effort, because the rate of transmission varies during an individual's infectious lifetime.</p>
<p>The model can now be described by specifying for the events <italic>E</italic> listed in <xref ref-type="table" rid="pcbi-1003899-t002">Table 2</xref>, their threshold-distribution <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e233" xlink:type="simple"/></inline-formula>, their ‘rates’ <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e234" xlink:type="simple"/></inline-formula>, and the precise actions on the state (see <xref ref-type="table" rid="pcbi-1003899-t003">Table 3</xref>).</p>
<table-wrap id="pcbi-1003899-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1003899.t003</object-id><label>Table 3</label><caption>
<title>Threshold distributions, rates, and actions for the events in the model.</title>
</caption><alternatives><graphic id="pcbi-1003899-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1003899.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e235" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e236" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e237" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">actions</td>
</tr>
</thead>
<tbody>
<tr>
<td colspan="2" align="left" rowspan="1"><italic>within-host level</italic></td>
<td colspan="2" align="left" rowspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">escape mutation</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e238" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e239" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e240" xlink:type="simple"/></inline-formula>, create new escape mutation event</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">reversion</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e241" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e242" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e243" xlink:type="simple"/></inline-formula>, create new reversion event</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">phase change (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e244" xlink:type="simple"/></inline-formula>)</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e245" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e246" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">change the phase into ‘asymptomatic’, create a new phase change event</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">phase change (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e247" xlink:type="simple"/></inline-formula>)</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e248" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e249" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">change the phase into ‘AIDS phase’, create a new phase change event</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">phase change (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e250" xlink:type="simple"/></inline-formula>)</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e251" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e252" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1">end of the within-host simulation</td>
</tr>
<tr>
<td colspan="2" align="left" rowspan="1"><italic>between-host level</italic></td>
<td colspan="2" align="left" rowspan="1"/>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">transmission</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e253" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e254" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e255" xlink:type="simple"/></inline-formula>, create a new infected individual, create a new transmission event for both the transmitting and the receiving host</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">death</td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e256" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e257" xlink:type="simple"/></inline-formula></td>
<td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e258" xlink:type="simple"/></inline-formula>, remove the deceased host</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p>The functions <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e259" xlink:type="simple"/></inline-formula> for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e260" xlink:type="simple"/></inline-formula> are here defined by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e261" xlink:type="simple"/></inline-formula>, if the patients disease is in the acute phase, and similarly <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e262" xlink:type="simple"/></inline-formula> for the asymptomatic phase, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e263" xlink:type="simple"/></inline-formula> for the AIDS phase. The function <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e264" xlink:type="simple"/></inline-formula> describes the viral load during the asymptomatic phase (that may not be constant due to escape mutations and reversions). The shape parameter <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e265" xlink:type="simple"/></inline-formula> for the Gamma distribution was estimated by Fraser et al. <xref ref-type="bibr" rid="pcbi.1003899-Fraser1">[17]</xref>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4b">
<title>Stochastic computation of the next-generation matrix</title>
<p>In order to study the steady state of the above described model, we developed a faster and more accurate method. In deterministic (e.g. ODE-based) models with multiple viral strains, one can compute the next-generation matrix (NGM), using the model's rate equations <xref ref-type="bibr" rid="pcbi.1003899-vandenDriessche1">[67]</xref>. Given a ‘generation’ (i.e., a distribution of strains in a cohort of newly infected individuals), the NGM gives the ‘next generation’ after mutation and selection in a discrete generation-based model. The steady states of the original (continuous time) and generation-based model coincide. This steady state can be computed by finding the dominant eigenvector of the NGM. The dominant eigenvalue equals (by definition) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e266" xlink:type="simple"/></inline-formula> <xref ref-type="bibr" rid="pcbi.1003899-Diekmann1">[68]</xref>.</p>
<p>Our model is not deterministic, but we can approximate the NGM using a Monte-Carlo method. We start with a virus that has <italic>m</italic><sub>1</sub> mutations. We then infect a large cohort (of size <italic>N</italic>) of individuals. These individuals may have different binding repertoires (of diverse size <italic>k</italic>), so we first sample pairs (<italic>e</italic><sub>1</sub>,<italic>f</italic><sub>1</sub>) with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e267" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e268" xlink:type="simple"/></inline-formula>. Then we run a within-host simulation for each of the virus-host pairs. Finally, we sample strains (<italic>e</italic>,<italic>f</italic>) that would be transmitted by the hosts at the start of an epidemic, and we count the number of transmitted stains <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e269" xlink:type="simple"/></inline-formula> that have <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e270" xlink:type="simple"/></inline-formula> mutations. The vector <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e271" xlink:type="simple"/></inline-formula> with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e272" xlink:type="simple"/></inline-formula> approximates the <italic>m</italic><sub>1</sub>-th column of the NGM.</p>
<p>If the sample size <italic>N</italic> is large enough, the dominant eigenvalue and corresponding right eigenvector of the matrix <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e273" xlink:type="simple"/></inline-formula> approximate, respectively, <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e274" xlink:type="simple"/></inline-formula> and the steady state distribution of prevalent viral strains in our agent-based model. By sampling strains from the steady-state distribution, and simulating infections with these strains, we can compute statistics as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e275" xlink:type="simple"/></inline-formula> in equilibrium. This method is not based on formal arguments, but below we put forward some heuristic evidence for its correctness.</p>
</sec><sec id="s4c">
<title>Estimating heritability</title>
<p>For the statistic heritability (<italic>h</italic><sup>2</sup>), the above scheme is insufficient. However, we do have a cohort of potential transmitters, and hence we can create transmission couples by first sampling transmitted strains from the cohorts’ individuals, and then infecting recipients. The statistic <italic>h</italic><sup>2</sup> is computed as the slope of the regression between the spVL of transmitters and receivers.</p>
<p>Classically, heritability of a trait <italic>x</italic> is defined as the proportion of variance in <italic>x</italic> that is caused by inherited genetic factors [see e.g. 18]. Hence, if we write <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e276" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e277" xlink:type="simple"/></inline-formula> is a genetic, and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e278" xlink:type="simple"/></inline-formula> an environmental factor, then <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e279" xlink:type="simple"/></inline-formula>. The slope of the regression mentioned above is an estimator for this quantity, but only when the transmitted quantity <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e280" xlink:type="simple"/></inline-formula> in the recipient is independent of the the transmitter's environmental factor <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e281" xlink:type="simple"/></inline-formula>. Below we will see that such an independence assumption does not hold for our model, and that the use of transmission couples results in an over-estimate of spVL heritability.</p>
</sec><sec id="s4d">
<title>Quantification of the footprint effect on heritability of spVL</title>
<p>To quantify the effect of the immunological footprint on heritability, we use a structural equation model (SEM), depicted as a directed, acyclic graph (DAG) in <xref ref-type="fig" rid="pcbi-1003899-g007">Figure 7</xref>. In our model, the actual inherited quantity is the number of mutated peptides <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e282" xlink:type="simple"/></inline-formula>. During an infection this quantity can change due to escapes and reversions, so we will only incorporate the number of mutations at the moment of infection (<italic>m</italic><sub>tra</sub> for a transmitting host, and <italic>m</italic><sub>rec</sub> for the corresponding receiver) in our statistical model.</p>
<p>The set-point virus load of the receiver (spVL<sub>rec</sub>) depends on <italic>m</italic><sub>rec</sub>, and the breadth of the immune response against the wild-type virus (<italic>k</italic><sub>rec</sub>). Of course, more factors determine the set-point virus load, such as the initial number of escape mutations, and stochastic effects such as mutations and progression to AIDS, but the simplified SEM only contains the variables spVL, <italic>m</italic> and <italic>k</italic>.</p>
<p>Apart from <italic>k</italic><sub>tra</sub>, the breadth of the transmitter's immune response and <italic>m</italic><sub>tra</sub>, the set-point virus load of the transmitter (spVL<sub>tra</sub>) depends also on <italic>m</italic><sub>rec</sub>. This is because the set-point is an average over the chronic phase, and hence, the transmitted virus co-determines the set-point of the transmitter. In <xref ref-type="fig" rid="pcbi-1003899-g007">Figure 7</xref>, this is indicated by the arrow <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e283" xlink:type="simple"/></inline-formula>.</p>
<p>During infection of the transmitter, the virus escapes a number of immune responses, and this number is dependent on <italic>k</italic><sub>tra</sub>. This means that <italic>k</italic><sub>tra</sub> influences the number of mutations of the transmitted virus <italic>m</italic><sub>rec</sub>. This ‘immunological footprint’ is represented by the arrow <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e284" xlink:type="simple"/></inline-formula> in <xref ref-type="fig" rid="pcbi-1003899-g007">Figure 7</xref>. The breadth of the immune response <italic>k</italic><sub>tra</sub> has no direct effect on <italic>m</italic><sub>tra</sub>, since <italic>m</italic><sub>tra</sub> corresponds to the transmitter's founder virus. Likewise, there is no direct effect of <italic>k</italic><sub>rec</sub> on <italic>m</italic><sub>rec</sub>.</p>
<p>We use the the R package lavaan <xref ref-type="bibr" rid="pcbi.1003899-Rosseel1">[69]</xref> to fit the model to (standardized) simulated data, that were produced using the NGM method and the standard model's parameters. As an example, the result of one of such fits is given in <xref ref-type="fig" rid="pcbi-1003899-g007">Figure 7</xref>. In this graph, the numbers above the arrows indicate the estimated weights. The maximal virus load <italic>V</italic><sub>max</sub> equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e285" xlink:type="simple"/></inline-formula> copies per ml, and the mutation rate <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e286" xlink:type="simple"/></inline-formula> equals 3y<sup>−1</sup>, such that the mean set-point for this population is 4.51 log<sub>10</sub>ml<sup>−1</sup> (cf. <xref ref-type="fig" rid="pcbi-1003899-g004">Figure 4A</xref>). Despite the large sample size of 25690 transmission couples, and the fact that the SEM has 4 degrees of freedom, the model describes the data quite well (the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e287" xlink:type="simple"/></inline-formula>-test's <italic>p</italic>-value equals 0.81, and the root mean square error of approximation (RMSEA) equals 0 with a 90% CI of [0,0.01]).</p>
<p>In the context of our SEM, the statistic <italic>h</italic><sup>2</sup> equals the correlation between spVL<sub>rec</sub> and spVL<sub>tra</sub>. This correlation can be computed as the sum of the contributions of all paths that connect spVL<sub>tra</sub> with spVL<sub>rec</sub>. The contribution of each path equals the product of the coefficients along the path. The 3 paths that connect spVL<sub>tra</sub> with spVL<sub>rec</sub> are: <disp-formula id="pcbi.1003899.e288"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e288" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e289"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e289" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e290"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e290" xlink:type="simple"/></disp-formula>where <italic>P</italic><sub>3</sub> is responsible for the immunological footprint. In the example of <xref ref-type="fig" rid="pcbi-1003899-g007">Figure 7</xref>, the contribution of <italic>P</italic><sub>3</sub> equals 0.082, which is about half (49.7%) of the total correlation between spVL<sub>rec</sub> and spVL<sub>tra</sub> (i.e., of the heritability). We refer to the contribution of the path <italic>P</italic><sub>3</sub> as the “contribution of the immunological footprint to heritability”.</p>
</sec><sec id="s4e">
<title>A comparison of HIV-1 clades B and C</title>
<p>We downloaded representative sequences for clades B and C from LANL's HIV sequence database (<ext-link ext-link-type="uri" xlink:href="http://www.hiv.lanl.gov" xlink:type="simple">www.hiv.lanl.gov</ext-link>; four sequences for each clade, as described in <xref ref-type="bibr" rid="pcbi.1003899-Leitner1">[70]</xref>). Then, we downloaded the HLA-A and HLA-B distributions for Europe and Sub-Saharan Africa from the NCBI database dbMHC (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/gv/mhc" xlink:type="simple">www.ncbi.nlm.nih.gov/projects/gv/mhc</ext-link>, <xref ref-type="bibr" rid="pcbi.1003899-Meyer1">[71]</xref>). Using the MHC binding predictor NetMHCpan (version 2.4 <xref ref-type="bibr" rid="pcbi.1003899-Hoof1">[45]</xref>), we computed binding affinities of all 9-mers from the representative strains for the most common HLA alleles (covering 95% of the populations). For each HLA molecule, the binding threshold was chosen such that the top 1% of a set of 10<sup>5</sup> naturally occurring peptides would be considered a binder (as described in <xref ref-type="bibr" rid="pcbi.1003899-vanDeutekom2">[72]</xref>).</p>
<p>For our analysis, we sample pairs of HLA haplotypes from the HLA distributions of one of the populations (ignoring linkage disequilibrium), each haplotype consisting of two HLA-A alleles and two HLA-B alleles. For each two haplotypes, we then compare the similarity of the binding repertoires with respect to one of the four representative strains. As a measure of similarity, we use the Jaccard index (<italic>J</italic>): the size of the intersection, divided by the size of the union of the two binding repertoires. This gives us the distribution of similarity scores of a population with respect to a strain. <xref ref-type="fig" rid="pcbi-1003899-g008">Figure 8B</xref> depicts two of these distributions. The black bars correspond to the European population with respect to a clade B virus, and the gray bars to the Sub-Saharan population with respect to a clade C virus.</p>
<p>By comparing the similarity distributions of a Sub-Saharan with a European population (<xref ref-type="fig" rid="pcbi-1003899-g008">Figure 8B</xref>), we can assess the difference in heterogeneity between the two populations and clades. The right panel of <xref ref-type="fig" rid="pcbi-1003899-g008">Figure 8C</xref> depicts the medians (one value for each representative strain). The European medians are significantly higher than the Sub-Saharan medians. For a better comparison between two distributions, we use a <italic>U</italic>-statistic, defined as <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e291" xlink:type="simple"/></inline-formula>, where <italic>J</italic><sub>eur</sub> and <italic>J</italic><sub>afr</sub> are distributed as the European and Sub-Saharan similarity distributions, respectively (cf. the Mann-Whitney <italic>U</italic>-test). Hence, <italic>U</italic> equals the likelihood that a random haplotype pair in the European population shows more similarity than a random pair in the Sub-Saharan population. We have four clade B strains and four clade C strains, and hence we can compute 16 probabilities <italic>U</italic> (<xref ref-type="fig" rid="pcbi-1003899-g008">Figure 8C, right panel</xref>). They turn out to be significantly higher than 0.5, meaning that the European population, subject to clade <italic>B</italic> strains, is less heterogeneous than the Sub-Saharan population and clade C strains.</p>
</sec><sec id="s4f">
<title>Deterministic computation of the NGM</title>
<p>We model within-host escape and reversion with two Markov chains: <disp-formula id="pcbi.1003899.e292"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e292" xlink:type="simple"/></disp-formula></p>
<p>Let <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e293" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e294" xlink:type="simple"/></inline-formula> denote the probability at time <italic>t</italic> that during infection phase <italic>i</italic> the host is infected by a virus with <italic>e</italic> escape mutations and <italic>f</italic> deleterious mutations, respectively, given that phase <italic>i</italic> started with an <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e295" xlink:type="simple"/></inline-formula>-virus at time <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e296" xlink:type="simple"/></inline-formula>. These probabilities satisfy the Kolmogorov forward equations [see e.g. 73]. <disp-formula id="pcbi.1003899.e297"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e297" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e298"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e298" xlink:type="simple"/></disp-formula></p>
<p>Closed-form expressions for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e299" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e300" xlink:type="simple"/></inline-formula> are given by <disp-formula id="pcbi.1003899.e301"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e301" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e302"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e302" xlink:type="simple"/></disp-formula></p>
<p>The probability <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e303" xlink:type="simple"/></inline-formula> that the host is infected with an (<italic>e</italic>,<italic>f</italic>) -virus only makes sense if we condition on the infection still being in phase <italic>i</italic>. We want to get the expected number of transmitted virus of a specific type, and in order to make the calculations possible, we take exponential distributions for the length of the phases. We tested that this assumption is not crucial by considering Erlang distributions. The rate at which phase <italic>i</italic> ends is given by <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e304" xlink:type="simple"/></inline-formula>. We also assume that mutation during the asymptomatic phase is slow and that the spVL is determined by the virus at the end of the acute phase (which is of type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e305" xlink:type="simple"/></inline-formula>). This means that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e306" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e307" xlink:type="simple"/></inline-formula> can be kept constant. Furthermore, the fraction of susceptibles (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e308" xlink:type="simple"/></inline-formula>) can be kept constant, either because the population is in a steady state, or because the epidemic has just started (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e309" xlink:type="simple"/></inline-formula>).</p>
<p>Consider the probability generating function [cf. 74] for the number of transmitted virus of type <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e310" xlink:type="simple"/></inline-formula> during phase <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e311" xlink:type="simple"/></inline-formula>: <disp-formula id="pcbi.1003899.e312"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e312" xlink:type="simple"/></disp-formula></p>
<p>Assuming that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e313" xlink:type="simple"/></inline-formula>, we can write this integral in terms of the Beta function (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e314" xlink:type="simple"/></inline-formula>). First we substitute the above given expressions for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e315" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e316" xlink:type="simple"/></inline-formula> <disp-formula id="pcbi.1003899.e317"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e317" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e318"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e318" xlink:type="simple"/></disp-formula>and when we now assume that <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e319" xlink:type="simple"/></inline-formula>, we can get</p>
<p><disp-formula id="pcbi.1003899.e320"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e320" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e321"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e321" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e322"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e322" xlink:type="simple"/></disp-formula>which equals by definition <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e323" xlink:type="simple"/></inline-formula>.</p>
<p>Since one of the arguments in this Beta function is an integer, the function <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e324" xlink:type="simple"/></inline-formula> is rational: <disp-formula id="pcbi.1003899.e325"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e325" xlink:type="simple"/></disp-formula>where we use the (rising) Pochhammer symbol <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e326" xlink:type="simple"/></inline-formula>.</p>
<p>Now that we have this expression for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e327" xlink:type="simple"/></inline-formula>, we can exploit the probability generating function's useful properties. The number <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e328" xlink:type="simple"/></inline-formula> equals the probability that at the end of phase <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e329" xlink:type="simple"/></inline-formula>, the host is infected with an <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e330" xlink:type="simple"/></inline-formula>-virus. The expected number of transmitted <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e331" xlink:type="simple"/></inline-formula>-strains during phase <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e332" xlink:type="simple"/></inline-formula> equals <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e333" xlink:type="simple"/></inline-formula>. We use the following notation: <disp-formula id="pcbi.1003899.e334"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e334" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e335"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e335" xlink:type="simple"/></disp-formula></p>
<p>If we now take into account that a transmitted <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e336" xlink:type="simple"/></inline-formula>-virus has a different phenotype <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e337" xlink:type="simple"/></inline-formula> in the receiver (with probability given by the hypergeometric distribution), we can find the NGM for the case <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e338" xlink:type="simple"/></inline-formula>. We verified that for this part of the parameter space (i.e., <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e339" xlink:type="simple"/></inline-formula>), the deterministic and stochastic computation give the same results (not shown).</p>
</sec><sec id="s4g">
<title>The bifurcation in the model with a homogeneous host population</title>
<p>When the host population is homogeneous (<inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e340" xlink:type="simple"/></inline-formula>), we find a threshold in the parameter space across which between-host adaptation is no longer possible. Here we will make this precise and show that this threshold is caused by a transcritical bifurcation. In a homogeneous population, we lose deleterious mutations. In the above introduced notation, we may ignore <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e341" xlink:type="simple"/></inline-formula> and we write for instance <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e342" xlink:type="simple"/></inline-formula>. Let <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e343" xlink:type="simple"/></inline-formula> denote the NGM, then we get the following formula in terms of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e344" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e345" xlink:type="simple"/></inline-formula>: <disp-formula id="pcbi.1003899.e346"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e346" xlink:type="simple"/></disp-formula></p>
<p>The matrix <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e347" xlink:type="simple"/></inline-formula> is triangular, since the number of escape mutations, which equals the total number of mutations, can only grow during an infection. The diagonal elements of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e348" xlink:type="simple"/></inline-formula> are the eigenvalues of <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e349" xlink:type="simple"/></inline-formula>, and the dominant eigenvalue equals (by definition) <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e350" xlink:type="simple"/></inline-formula> of the quasi-species. The diagonal elements can be written as <disp-formula id="pcbi.1003899.e351"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e351" xlink:type="simple"/></disp-formula></p>
<p>If <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e352" xlink:type="simple"/></inline-formula> is dominant, then population-level evolution will result in strains that have escaped all CTL responses. If another eigenvalue <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e353" xlink:type="simple"/></inline-formula> with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e354" xlink:type="simple"/></inline-formula> is dominant, then not all viruses have escaped all CTL responses and this is due to selection for transmission on the population-level.</p>
<p>If we now fix <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e355" xlink:type="simple"/></inline-formula> and let <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e356" xlink:type="simple"/></inline-formula> approach <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e357" xlink:type="simple"/></inline-formula> from the right, then for high <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e358" xlink:type="simple"/></inline-formula> the eigenvalue <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e359" xlink:type="simple"/></inline-formula> is dominant. The mentioned bifurcation occurs when <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e360" xlink:type="simple"/></inline-formula> equals one of the <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e361" xlink:type="simple"/></inline-formula> (with <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e362" xlink:type="simple"/></inline-formula>) for the first time. We first give simple expressions for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e363" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e364" xlink:type="simple"/></inline-formula> that occur in the expression for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e365" xlink:type="simple"/></inline-formula>: <disp-formula id="pcbi.1003899.e366"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e366" xlink:type="simple"/></disp-formula><disp-formula id="pcbi.1003899.e367"><graphic position="anchor" xlink:href="info:doi/10.1371/journal.pcbi.1003899.e367" xlink:type="simple"/></disp-formula></p>
<p>These expressions and the formula for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e368" xlink:type="simple"/></inline-formula> enable us to (numerically) find the curves <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e369" xlink:type="simple"/></inline-formula> for <inline-formula><inline-graphic xlink:href="info:doi/10.1371/journal.pcbi.1003899.e370" xlink:type="simple"/></inline-formula>. These curves and the resulting threshold are shown in <xref ref-type="fig" rid="pcbi-1003899-g006">Figure 6</xref>.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1003899.s001" mimetype="application/x-gzip" xlink:href="info:doi/10.1371/journal.pcbi.1003899.s001" position="float" xlink:type="simple"><label>S1 File</label><caption>
<p><bold>The source code for the simulations.</bold> Information about compiling the code and running the simulation can be found in the <bold>README</bold> file.</p>
<p>(GZ)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>We thank Paola Carrillo-Bustamante, Rutger Woolthuis and Odo Diekmann for very useful discussions, and carefully reading the manuscript. We gratefully acknowledge Johannes Textor and Hanneke van Deutekom for technical support.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pcbi.1003899-Little1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Little</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>McLean</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Spina</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Richman</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Havlir</surname><given-names>DV</given-names></name> (<year>1999</year>) <article-title>Viral Dynamics of Acute HIV-1 Infection</article-title>. <source>The Journal of Experimental Medicine</source> <volume>190</volume>: <fpage>841</fpage>–<lpage>850</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Phillips1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Phillips</surname><given-names>AN</given-names></name> (<year>1996</year>) <article-title>Reduction of HIV concentration during acute infection: independence from a specific immune response</article-title>. <source>Science (New York, NY)</source> <volume>271</volume>: <fpage>497</fpage>–<lpage>499</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Fellay1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fellay</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shianna</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Colombo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ledergerber</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1</article-title>. <source>Science</source> <volume>317</volume>: <fpage>944</fpage>–<lpage>947</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Fellay2"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fellay</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ge</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Shianna</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Colombo</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ledergerber</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Common Genetic Variation and the Control of HIV-1 in Humans</article-title>. <source>PLoS Genet</source> <volume>5</volume>: <fpage>e1000791</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Leslie1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leslie</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Matthews</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Listgarten</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Carlson</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Kadie</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 Infection</article-title>. <source>Journal of Virology</source> <volume>84</volume>: <fpage>9879</fpage>–<lpage>9888</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-TheInternationalHIVControllers1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>The International HIV Controllers</surname><given-names>Study</given-names></name> (<year>2010</year>) <article-title>The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation</article-title>. <source>Science</source> <volume>330</volume>: <fpage>1551</fpage>–<lpage>1557</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Hollingsworth1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hollingsworth</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Laeyendecker</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Shirreff</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Donnelly</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Serwadda</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>HIV-1 Transmitting Couples Have Similar Viral Load Set-Points in Rakai, Uganda</article-title>. <source>PLoS Pathog</source> <volume>6</volume>: <fpage>e1000876</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Alizon1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alizon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>von Wyl</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Stadler</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kouyos</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Yerly</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load</article-title>. <source>PLoS Pathog</source> <volume>6</volume>: <fpage>e1001123</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Mller1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Müller</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Herbeck</surname><given-names>JT</given-names></name> (<year>2011</year>) <article-title>A Strong Case for Viral Genetic Factors in HIV Virulence</article-title>. <source>Viruses</source> <volume>3</volume>: <fpage>204</fpage>–<lpage>216</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Hodcroft1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hodcroft</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hadfield</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Fearnhill</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dunn</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>The Contribution of Viral Genotype to Plasma Viral Set-Point in HIV Infection</article-title>. <source>PLoS Pathog</source> <volume>10</volume>: <fpage>e1004112</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Yue1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yue</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Prentice</surname><given-names>HA</given-names></name>, <name name-style="western"><surname>Farmer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>W</given-names></name>, <name name-style="western"><surname>He</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Cumulative Impact of Host and Viral Factors on HIV-1 Viral-Load Control during Early Infection</article-title>. <source>Journal of Virology</source> <volume>87</volume>: <fpage>708</fpage>–<lpage>715</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-vanderKuyl1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van der Kuyl</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Jurriaans</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pollakis</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bakker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cornelissen</surname><given-names>M</given-names></name> (<year>2010</year>) <article-title>HIV RNA levels in transmission sources only weakly predict plasma viral load in recipients:</article-title>. <source>AIDS</source> <volume>24</volume>: <fpage>1607</fpage>–<lpage>1608</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Hecht1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hecht</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Hartogensis</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Bragg</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Bacchetti</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Atchison</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>HIV RNA level in early infection is predicted by viral load in the transmission source</article-title>. <source>AIDS April 24, 2010</source> <volume>24</volume>: <fpage>941</fpage>–<lpage>945</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Tang1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lobashevsky</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Zulu</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Aldrovandi</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>HLA Allele Sharing and HIV Type 1 Viremia in Seroconverting Zambians with Known Transmitting Partners</article-title>. <source>AIDS Research and Human Retroviruses</source> <volume>20</volume>: <fpage>19</fpage>–<lpage>25</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Wawer1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wawer</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Sewankambo</surname><given-names>NK</given-names></name>, <name name-style="western"><surname>Serwadda</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Rates of HIV-1 Transmission per Coital Act, by Stage of HIV-1 Infection, in Rakai, Uganda</article-title>. <source>Journal of Infectious Diseases</source> <volume>191</volume>: <fpage>1403</fpage>–<lpage>1409</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Mellors1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mellors</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Giorgi</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Margolick</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Tassoni</surname><given-names>CJ</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection</article-title>. <source>Annals of Internal Medicine</source> <volume>126</volume>: <fpage>946</fpage>–<lpage>954</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Fraser1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Hollingsworth</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Chapman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>de Wolf</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hanage</surname><given-names>WP</given-names></name> (<year>2007</year>) <article-title>Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis</article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>104</volume>: <fpage>17441</fpage>–<lpage>17446</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Shirreff1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shirreff</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Pellis</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Laeyendecker</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name> (<year>2011</year>) <article-title>Transmission Selects for HIV-1 Strains of Intermediate Virulence: A Modelling Approach</article-title>. <source>PLoS Comput Biol</source> <volume>7</volume>: <fpage>e1002185</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Worobey1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Worobey</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gemmel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Teuwen</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Haselkorn</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kunstman</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960</article-title>. <source>Nature</source> <volume>455</volume>: <fpage>661</fpage>–<lpage>664</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Sharp1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sharp</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Bailes</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Chaudhuri</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Rodenburg</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Santiago</surname><given-names>MO</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>The origins of acquired immune deficiency syndrome viruses: where and when?</article-title> <source>Philosophical Transactions of the Royal Society of London Series B: Biological Sciences</source> <volume>356</volume>: <fpage>867</fpage>–<lpage>876</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Lythgoe1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lythgoe</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Pellis</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name> (<year>2013</year>) <article-title>Is Hiv Short-Sighted? Insights from a Multistrain Nested Model</article-title>. <source>Evolution</source> <volume>67</volume>: <fpage>2769</fpage>–<lpage>2782</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Levin1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levin</surname><given-names>BR</given-names></name>, <name name-style="western"><surname>Bull</surname><given-names>JJ</given-names></name> (<year>1994</year>) <article-title>Short-sighted evolution and the virulence of pathogenic microorganisms</article-title>. <source>Trends in microbiology</source> <volume>2</volume>: <fpage>76</fpage>–<lpage>81</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Schmitz1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmitz</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Kuroda</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Santra</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sasseville</surname><given-names>VG</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>MA</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes</article-title>. <source>Science</source> <volume>283</volume>: <fpage>857</fpage>–<lpage>860</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Regoes1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Regoes</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Antia</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Garber</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Silvestri</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Feinberg</surname><given-names>MB</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Roles of Target Cells and Virus-Specific Cellular Immunity in Primary Simian Immunodeficiency Virus Infection</article-title>. <source>Journal of Virology</source> <volume>78</volume>: <fpage>4866</fpage>–<lpage>4875</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Liu1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ritchie</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Ganusov</surname><given-names>VV</given-names></name>, <name name-style="western"><surname>Whale</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Vertical T cell immunodominance and epitope entropy determine HIV-1 escape</article-title>. <source>The Journal of Clinical Investigation</source> <volume>123</volume>: <fpage>380</fpage>–<lpage>393</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Goonetilleke1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goonetilleke</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>MKP</given-names></name>, <name name-style="western"><surname>Salazar-Gonzalez</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Ferrari</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Giorgi</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection</article-title>. <source>The Journal of Experimental Medicine</source> <volume>206</volume>: <fpage>1253</fpage>–<lpage>1272</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Henn1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Henn</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Boutwell</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Charlebois</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lennon</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Power</surname><given-names>KA</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection</article-title>. <source>PLoS Pathog</source> <volume>8</volume>: <fpage>e1002529</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Goulder1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goulder</surname><given-names>PJR</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>DI</given-names></name> (<year>2008</year>) <article-title>Impact of MHC class I diversity on immune control of immunodeficiency virus replication</article-title>. <source>Nature Reviews Immunology</source> <volume>8</volume>: <fpage>619</fpage>–<lpage>630</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Goepfert1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goepfert</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Lumm</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Farmer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Matthews</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Prendergast</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients</article-title>. <source>The Journal of Experimental Medicine</source> <volume>205</volume>: <fpage>1009</fpage>–<lpage>1017</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Prince1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prince</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Claiborne</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Carlson</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Schaefer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Role of Transmitted Gag CTL Polymorphisms in Defining Replicative Capacity and Early HIV-1 Pathogenesis</article-title>. <source>PLoS Pathog</source> <volume>8</volume>: <fpage>e1003041</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Kadolsky1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kadolsky</surname><given-names>UD</given-names></name>, <name name-style="western"><surname>Asquith</surname><given-names>B</given-names></name> (<year>2010</year>) <article-title>Quantifying the Impact of Human Immunodeficiency Virus-1 Escape From Cytotoxic T-Lymphocytes</article-title>. <source>PLoS Comput Biol</source> <volume>6</volume>: <fpage>e1000981</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Kiepiela1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kiepiela</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ngumbela</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Thobakgale</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ramduth</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Honeyborne</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>CD8+ T-cell responses to different HIV proteins have discordant associations with viral load</article-title>. <source>Nature Medicine</source> <volume>13</volume>: <fpage>46</fpage>–<lpage>53</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Leslie2"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leslie</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Pfafferott</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Chetty</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Draenert</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Addo</surname><given-names>MM</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>HIV evolution: CTL escape mutation and reversion after transmission</article-title>. <source>Nature Medicine</source> <volume>10</volume>: <fpage>282</fpage>–<lpage>289</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Allen1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Allen</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Altfeld</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>XG</given-names></name>, <name name-style="western"><surname>O'Sullivan</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Lichterfeld</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection</article-title>. <source>Journal of Virology</source> <volume>78</volume>: <fpage>7069</fpage>–<lpage>7078</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Schmid1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmid</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ke,smir</surname><given-names>C</given-names></name>, <name name-style="western"><surname>de Boer</surname><given-names>R</given-names></name> (<year>2010</year>) <article-title>Quantifying how MHC polymorphism prevents pathogens from adapting to the antigen presentation pathway</article-title>. <source>Epidemics</source> <volume>2</volume>: <fpage>99</fpage>–<lpage>108</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Jin1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jin</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Tuttleton</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Lewin</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gettie</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques</article-title>. <source>The Journal of Experimental Medicine</source> <volume>189</volume>: <fpage>991</fpage>–<lpage>998</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Gaufin1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gaufin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ribeiro</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Gautam</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dufour</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mandell</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Experimental depletion of CD8+ cells in acutely SIVagm-Infected African Green Monkeys results in increased viral replication</article-title>. <source>Retrovirology</source> <volume>7</volume>: <fpage>42</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Leslie3"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leslie</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kavanagh</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Honeyborne</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Pfafferott</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA</article-title>. <source>J Exp Med</source> <volume>201</volume>: <fpage>891</fpage>–<lpage>902</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Rao1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>AICAF</given-names></name>, <name name-style="western"><surname>Baarle</surname><given-names>Dv</given-names></name>, <name name-style="western"><surname>Keşmir</surname><given-names>C</given-names></name> (<year>2009</year>) <article-title>A Comparative Study of HLA Binding Affinity and Ligand Diversity: Implications for Generating Immunodominant CD8+ T Cell Responses</article-title>. <source>The Journal of Immunology</source> <volume>182</volume>: <fpage>1526</fpage>–<lpage>1532</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Rao2"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rao</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Hoof</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>AICAF</given-names></name>, <name name-style="western"><surname>Baarle</surname><given-names>Dv</given-names></name>, <name name-style="western"><surname>Keşmir</surname><given-names>C</given-names></name> (<year>2011</year>) <article-title>HLA class I allele promiscuity revisited</article-title>. <source>Immunogenetics</source> <volume>63</volume>: <fpage>691</fpage>–<lpage>701</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Hollingsworth2"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hollingsworth</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name> (<year>2008</year>) <article-title>HIV-1 Transmission, by Stage of Infection</article-title>. <source>Journal of Infectious Diseases</source> <volume>198</volume>: <fpage>687</fpage>–<lpage>693</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Begon1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begon</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bowers</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>French</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Hazel</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>A clarification of transmission terms in host-microparasite models: numbers, densities and areas</article-title>. <source>Epidemiol Infect</source> <volume>129</volume>: <fpage>147</fpage>–<lpage>153</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Liu2"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>McNevin</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Holte</surname><given-names>S</given-names></name>, <name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Mullins</surname><given-names>JI</given-names></name> (<year>2011</year>) <article-title>Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection</article-title>. <source>PLoS ONE</source> <volume>6</volume>: <fpage>e15639</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Hodcroft2"><label>44</label>
<mixed-citation publication-type="other" xlink:type="simple">Hodcroft E, Fearnhill E, Phillips A, Dunn D, Pillay D, <etal>et al</etal>.. (2013). Viral Genotype in Subtype C Significantly Influences Plasma Viral Load. Poster presentation 258b at CROI 2013.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Hoof1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hoof</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Peters</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Sidney</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Pedersen</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Sette</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>NetMHCpan, a method for MHC class I binding prediction beyond humans</article-title>. <source>Immunogenetics</source> <volume>61</volume>: <fpage>1</fpage>–<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-vanDeutekom1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Deutekom</surname><given-names>HWM</given-names></name>, <name name-style="western"><surname>Wijnker</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Boer</surname><given-names>RJd</given-names></name> (<year>2013</year>) <article-title>The Rate of Immune Escape Vanishes When Multiple Immune Responses Control an HIV Infection</article-title>. <source>The Journal of Immunology</source> <volume>191</volume>: <fpage>3277</fpage>–<lpage>3286</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Dorak1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dorak</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Penman-Aguilar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Westfall</surname><given-names>AO</given-names></name>, <name name-style="western"><surname>Zulu</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples</article-title>. <source>Lancet</source> <volume>363</volume>: <fpage>2137</fpage>–<lpage>2139</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Herbeck1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herbeck</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Müller</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Maust</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Ledergerber</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Torti</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission</article-title>. <source>AIDS January 14, 2012</source> <volume>26</volume>: <fpage>193</fpage>–<lpage>205</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Lythgoe2"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lythgoe</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name> (<year>2012</year>) <article-title>New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels</article-title>. <source>Proceedings of the Royal Society B: Biological Sciences</source> <volume>279</volume>: <fpage>3367</fpage>–<lpage>3375</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Hool1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hool</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Leventhal</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Bonhoeffer</surname><given-names>S</given-names></name> (<year>2013</year>) <article-title>Virus-induced target cell activation reconciles set-point viral load heritability and within-host evolution</article-title>. <source>Epidemics</source> <volume>5</volume>: <fpage>174</fpage>–<lpage>180</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Fraser2"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lythgoe</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Leventhal</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Shirreff</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Hollingsworth</surname><given-names>TD</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective</article-title>. <source>Science</source> <volume>343</volume>: <fpage>1243727</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Alizon2"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alizon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fraser</surname><given-names>C</given-names></name> (<year>2013</year>) <article-title>Within-host and between-host evolutionary rates across the HIV-1 genome</article-title>. <source>Retrovirology</source> <volume>10</volume>: <fpage>49</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Carlson1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carlson</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Schaefer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Monaco</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Batorsky</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Claiborne</surname><given-names>DT</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck</article-title>. <source>Science</source> <volume>345</volume>: <fpage>1254031</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Moore1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moore</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>John</surname><given-names>M</given-names></name>, <name name-style="western"><surname>James</surname><given-names>IR</given-names></name>, <name name-style="western"><surname>Christiansen</surname><given-names>FT</given-names></name>, <name name-style="western"><surname>Witt</surname><given-names>CS</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level</article-title>. <source>Science</source> <volume>296</volume>: <fpage>1439</fpage>–<lpage>1443</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Kawashima1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kawashima</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Pfafferott</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Frater</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Matthews</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Payne</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Adaptation of HIV-1 to human leukocyte antigen class I</article-title>. <source>Nature</source> <volume>458</volume>: <fpage>641</fpage>–<lpage>645</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Dong1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dong</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>H</given-names></name>, <name name-style="western"><surname>James</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China</article-title>. <source>Blood</source> <volume>118</volume>: <fpage>98</fpage>–<lpage>106</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Schellens1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schellens</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Navis</surname><given-names>M</given-names></name>, <name name-style="western"><surname>van Deutekom</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Boeser-Nunnink</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Berkhout</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Loss of HIV-1-derived cytotoxic T lymphocyte epitopes restricted by protective HLA-B alleles during the HIV-1 epidemic:</article-title>. <source>AIDS</source> <volume>25</volume>: <fpage>1691</fpage>–<lpage>1700</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Bartha1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bartha</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Simon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Müller</surname><given-names>V</given-names></name> (<year>2008</year>) <article-title>Has HIV evolved to induce immune pathogenesis?</article-title> <source>Trends in Immunology</source> <volume>29</volume>: <fpage>322</fpage>–<lpage>328</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Sanjun1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sanjuán</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Nebot</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Peris</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Alcamí</surname><given-names>J</given-names></name> (<year>2013</year>) <article-title>Immune Activation Promotes Evolutionary Conservation of T-Cell Epitopes in HIV-1</article-title>. <source>PLoS Biol</source> <volume>11</volume>: <fpage>e1001523</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Asquith1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Asquith</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>CTT</given-names></name>, <name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McLean</surname><given-names>AR</given-names></name> (<year>2006</year>) <article-title>Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo</article-title>. <source>PLoS Biol</source> <volume>4</volume>: <fpage>e90</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Kessinger1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kessinger</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Perelson</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Neher</surname><given-names>RA</given-names></name> (<year>2013</year>) <article-title>Inferring HIV escape rates from multi-locus genotype data</article-title>. <source>Frontiers in T Cell Biology</source> <volume>4</volume>: <fpage>252</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Leviyang1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leviyang</surname><given-names>S</given-names></name> (<year>2013</year>) <article-title>Computational inference methods for selective sweeps arising in acute HIV infection</article-title>. <source>Genetics</source> <volume>194</volume>: <fpage>737</fpage>–<lpage>752</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Lang1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lang</surname><given-names>GI</given-names></name>, <name name-style="western"><surname>Rice</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Hickman</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Sodergren</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Weinstock</surname><given-names>GM</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations</article-title>. <source>Nature</source> <volume>500</volume>: <fpage>571</fpage>–<lpage>574</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Strelkowa1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Strelkowa</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Lässig</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Clonal Interference in the Evolution of Influenza</article-title>. <source>Genetics</source> <volume>192</volume>: <fpage>671</fpage>–<lpage>682</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Pandit1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pandit</surname><given-names>A</given-names></name>, <name name-style="western"><surname>de Boer</surname><given-names>RJ</given-names></name> (<year>2014</year>) <article-title>Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants</article-title>. <source>Retrovirology</source> <volume>11</volume>: <fpage>56</fpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Sellke1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sellke</surname><given-names>T</given-names></name> (<year>1983</year>) <article-title>On the Asymptotic Distribution of the Size of a Stochastic Epidemic</article-title>. <source>Journal of Applied Probability</source> <volume>20</volume>: <fpage>390</fpage>–<lpage>394</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-vandenDriessche1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van den Driessche</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Watmough</surname><given-names>J</given-names></name> (<year>2002</year>) <article-title>Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission</article-title>. <source>Math Biosci</source> <volume>180</volume>: <fpage>29</fpage>–<lpage>48</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Diekmann1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Diekmann</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Heesterbeek</surname><given-names>JAP</given-names></name>, <name name-style="western"><surname>Metz</surname><given-names>JAJ</given-names></name> (<year>1990</year>) <article-title>On the definition and the computation of the basic reproduction ratio R 0 in models for infectious diseases in heterogeneous populations</article-title>. <source>Journal of Mathematical Biology</source> <volume>28</volume>: <fpage>365</fpage>–<lpage>382</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Rosseel1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosseel</surname><given-names>Y</given-names></name> (<year>2012</year>) <article-title>lavaan: An r package for structural equation modeling</article-title>. <source>Journal of Statistical Software</source> <volume>48</volume>: <fpage>1</fpage>–<lpage>36</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Leitner1"><label>70</label>
<mixed-citation publication-type="book" xlink:type="simple">Leitner T, Korber B, Daniels M, Calef C, Foley B (2005) HIV-1 subtype and circulating recombinant form (CRF) reference sequences. In: Leitner T, Foley B, Hahn B, Marx P, McCutchan F, editors, HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, pp. 41–48.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Meyer1"><label>71</label>
<mixed-citation publication-type="book" xlink:type="simple">Meyer D, Singe RM, Mack SJ, Lancaster A, Nelson MP, <etal>et al</etal>.. (2007) Single locus polymorphism of classical hla genes. In: Hansen JA, editors, Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference, <volume>Volume I</volume> . IHWG Press, pp. 653–704.</mixed-citation>
</ref>
<ref id="pcbi.1003899-vanDeutekom2"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van Deutekom</surname><given-names>HW</given-names></name>, <name name-style="western"><surname>Hoof</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bontrop</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Keşmir</surname><given-names>C</given-names></name> (<year>2011</year>) <article-title>A comparative analysis of viral peptides presented by contemporary human and chimpanzee MHC class I molecules</article-title>. <source>J Immunol</source> <volume>187</volume>: <fpage>5995</fpage>–<lpage>6001</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Norris1"><label>73</label>
<mixed-citation publication-type="other" xlink:type="simple">Norris JR (1998) Markov Chains. Cambridge University Press.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Diekmann2"><label>74</label>
<mixed-citation publication-type="other" xlink:type="simple">Diekmann O, Heesterbeek H, Britton T (2013) Mathematical Tools for Understanding Infectious Disease Dynamics. Princeton University Press.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Nowak1"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nowak</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>May</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Rowland-Jones</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Lalloo</surname><given-names>DG</given-names></name>, <etal>et al</etal>. (<year>1995</year>) <article-title>Antigenic oscillations and shifting immunodominance in HIV-1 infections</article-title>. <source>Nature</source> <volume>375</volume>: <fpage>606</fpage>–<lpage>611</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Fernandez1"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fernandez</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Batten</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Rose</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Reece</surname><given-names>JC</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Vaccine-Induced T Cells Control Reversion of AIDS Virus Immune Escape Mutants</article-title>. <source>Journal of Virology</source> <volume>81</volume>: <fpage>4137</fpage>–<lpage>4144</lpage>.</mixed-citation>
</ref>
<ref id="pcbi.1003899-Fryer1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fryer</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Frater</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Duda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>RE</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Modelling the Evolution and Spread of HIV Immune Escape Mutants</article-title>. <source>PLoS Pathog</source> <volume>6</volume>: <fpage>e1001196</fpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>